<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
<channel>        <title><![CDATA[Eye MD&#39;s Blog]]></title>
        <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr]]></link>
        <description><![CDATA[三不五時 , Eye要及時]]></description>
  <lastBuildDate>Sun, 08 Nov 2009 11:08:07 +0800</lastBuildDate>
        <language>zh-tw</language>         <item>
            <title><![CDATA[2009大稻埕煙火節]]></title>
            <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4481]]></link>
            <description><![CDATA[<p><span class="story_title">倒數迎花博 璀璨大稻埕</span><br><span class="story_sub_title">120組花卉煙火 長達30分鐘 市縣65萬人觀賞 還有南部民眾包遊覽車來看</span> </p>
<p><br><img src="http://tw.blog.yahoo.com/photo/photo.php?id=HSPM5qCVERshgArt8Sfx&amp;photo=tn_F23_20091108124337277.jpg"/><br></p>
<table cellSpacing="5" cellPadding="5" width="98%" align="center" border="0">
<tbody>
<tr>
<td class="story" align="left">
<p>「嘩！滿天都是煙火，好壯觀」！台北市政府昨晚在大稻埕碼頭舉辦「倒數迎花博─2009大稻埕煙火節」，長達30分鐘、超過120組花卉造型煙火照亮<font color="red">淡水</font>河面，尤其最後在河道上三個施放點同時施放的大型煙火，由高空像花火瀑布般洩落，讓民眾驚呼不已。 
<p>
<p>市府估計，昨晚煙火吸引北市45萬人次、北縣20萬人次，共65萬人次觀賞，比去年多出6萬人次，還有南部民眾包遊覽車北上專程來看煙火。 ........... 
<p><img src="http://tw.blog.yahoo.com/photo/photo.php?id=HSPM5qCVERshgArt8Sfx&amp;photo=tn_F23_20091108124322739.jpg"/>
<p>此次煙火節預算共550萬元，煙火部分400萬元，煙火樣式及精采度獲得在場民眾高度好評，有民眾舉起手機記錄煙火，一舉就是30分鐘。 
<p>
<p></p>
<p>【2009-11-08/聯合報/B1版/北市．運動】</p>
<p><img src="http://tw.blog.yahoo.com/photo/photo.php?id=HSPM5qCVERshgArt8Sfx&amp;photo=tn_F23_20091108124530823.jpg"/></p>
</td></tr></tbody></table>]]></description>
            <pubDate>Sun, 08 Nov 2009 11:08:07 +0800</pubDate>
            <guid><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4481]]></guid>
         </item>         <item>
            <title><![CDATA[陽明山恐火山爆發]]></title>
            <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4465]]></link>
            <description><![CDATA[<p class="MsoNormal" style="BACKGROUND:white;MARGIN:0pt;"><strong><span style="FONT-SIZE:20pt;COLOR:black;FONT-FAMILY:標楷體;"></span></strong>&nbsp;</p>
<p class="MsoNormal" style="BACKGROUND:white;MARGIN:0pt;"><strong><span style="FONT-SIZE:20pt;COLOR:black;FONT-FAMILY:標楷體;">「活」大屯火山恐爆發？　學者籲監測<span lang="EN-US"></span></span></strong></p>
<p class="MsoNormal" style="BACKGROUND:white;MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:9.5pt;COLOR:#333333;FONT-FAMILY:Arial;"><a href="http://tw.rd.yahoo.com/referurl/news/logo/tvbs/SIG=10vc53r83/*http:/www.tvbs.com.tw/index/" target="_blank"><span style="COLOR:#003399;TEXT-DECORATION:none;"></span></a></span><span style="FONT-SIZE:9.5pt;COLOR:#333333;FONT-FAMILY:細明體;">更新日期<span lang="EN-US">:2009/11/01 12:15</span></span><span lang="EN-US" style="FONT-SIZE:9.5pt;COLOR:#333333;FONT-FAMILY:Arial;"> </span><em><span style="FONT-SIZE:9.5pt;COLOR:#333333;FONT-FAMILY:細明體;">吳御曄</span></em><span style="FONT-SIZE:9.5pt;COLOR:#333333;FONT-FAMILY:Arial;"> <span lang="EN-US"></span></span></p>
<table class="MsoNormalTable" cellSpacing="0" cellPadding="0" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;PADDING-BOTTOM:1pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:3pt 0pt;TEXT-ALIGN:center;" align="center"><span lang="EN-US" style="FONT-SIZE:9.5pt;COLOR:#333333;FONT-FAMILY:Arial;"></span>&nbsp;</p>
</td></tr></tbody></table>
<p class="MsoNormal" style="BACKGROUND:white;MARGIN:0pt 0pt 14.4pt;"><span style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:新細明體;">台北市民要小心火山爆發？中研院最新研究發現，原本一直以為是休火山的大屯山，其實最近的爆發時間，比先前研究來的早，大概在</span><strong><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:red;FONT-FAMILY:Arial;">5</span></strong><strong><span style="FONT-SIZE:11.5pt;COLOR:red;FONT-FAMILY:新細明體;">千年前還有過活動，因此不是休火山而是活火山</span></strong><span style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:新細明體;">，專家提醒，政府應該在山上建立火山監測系統，盯緊大屯山的活動，因為一但爆發，將影響全台北人民的安全。</span><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:Arial;"></span></p>
<p class="MsoNormal" style="BACKGROUND:white;MARGIN:0pt;"><span style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:新細明體;">小油坑冒濃煙，像這樣的火山景觀，</span><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:Arial;"><a title="&#x00967d;&#x00660e;&#x005c71;" href="http://tw.news.yahoo.com/article/url/d/a/091101/8/?"><span style="FONT-SIZE:14pt;BACKGROUND:white;COLOR:#003399;FONT-FAMILY:新細明體;">陽明山</span></a></span><span style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:新細明體;">到處都是，但中研院研究員發現，大屯山根本不是休火山，而是還在活動的活火山。</span><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:Arial;"><a title="&#x0053f0;&#x005927;" href="http://tw.news.yahoo.com/article/url/d/a/091101/8/?"><span style="FONT-SIZE:14pt;BACKGROUND:white;COLOR:#003399;FONT-FAMILY:新細明體;">台大</span></a></span><span style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:新細明體;">地質教授陳宏宇：「地形、地貌，還有一些地質上的條件，很可能還存在有些噴氣，有些微地動的出現。」</span><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:Arial;"></span></p>
<p class="MsoNormal" style="BACKGROUND:white;MARGIN:0pt 0pt 14.4pt;"><span style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:新細明體;">差一個字，差很大，因為</span><strong><span style="FONT-SIZE:11.5pt;COLOR:red;FONT-FAMILY:新細明體;">按照原本的史料和地質研究大屯山上一次爆發是</span></strong><strong><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:red;FONT-FAMILY:Arial;">20</span></strong><strong><span style="FONT-SIZE:11.5pt;COLOR:red;FONT-FAMILY:新細明體;">萬年前的事情，但是中研院研究火山灰，卻發現最近一次大屯山的火山爆發，其實是在</span></strong><strong><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:red;FONT-FAMILY:Arial;">5000</span></strong><strong><span style="FONT-SIZE:11.5pt;COLOR:red;FONT-FAMILY:新細明體;">年前。</span></strong><strong><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:red;FONT-FAMILY:Arial;"></span></strong></p>
<p class="MsoNormal" style="BACKGROUND:white;MARGIN:0pt 0pt 14.4pt;"><span style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:新細明體;">這樣一來，就不是原本定義的休火山而是活火山，意思就是大屯山，可能會爆發嗎？陳宏宇：「我覺得政府應該好好投入，一些心力因為畢竟陽明山，整個範圍，相關於整個台北都會區，這個研究值得推廣。」</span><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:Arial;"></span></p>
<p class="MsoNormal" style="BACKGROUND:white;MARGIN:0pt 0pt 14.4pt;"><span style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:新細明體;">提醒政府一定得盯好大屯山的活動，因為目前國內還沒有類似這樣的火山測報系統，再加上大屯山一爆發，首當其衝影響的除了上次爆發範圍的士林北投，還有台北市</span><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:Arial;">260</span><span style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:新細明體;">萬的人生命安全，一點都不能輕忽。</span><span lang="EN-US" style="FONT-SIZE:11.5pt;COLOR:#333333;FONT-FAMILY:Arial;"></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US"><font face="Times New Roman" size="3"></font></span>&nbsp;</p>]]></description>
            <pubDate>Sun, 01 Nov 2009 20:58:31 +0800</pubDate>
            <guid><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4465]]></guid>
         </item>         <item>
            <title><![CDATA[法 界 奇 蹟!   醫 界 之 悲 哀]]></title>
            <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4464]]></link>
            <description><![CDATA[<p class="MsoNormal" style="MARGIN:0pt;"><strong><span style="FONT-SIZE:24pt;FONT-FAMILY:新細明體;"></span></strong>&nbsp;</p>
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span style="FONT-SIZE:24pt;FONT-FAMILY:新細明體;">隱形眼鏡拔不出醫誤診判５月<span lang="EN-US"></span></span></strong></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><em><span lang="EN-US" style="FONT-FAMILY:新細明體;">2009年10月30日蘋果日報</span></em><span style="FONT-FAMILY:新細明體;"> <span lang="EN-US"></span></span></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span style="FONT-FAMILY:新細明體;"><font size="3">【連線報導】女子藍<span lang="EN-US">xx因隱形眼鏡拔不下來，到蔡xx眼科診所就醫，蔡醫師卻誤診為結膜炎，只幫她點眼藥水，<strong><span style="COLOR:fuchsia;">當晚藍女痛到受不了，到其他<u>醫院</u>求診，才發現蔡XX根本沒幫她取下眼鏡，導致角膜潰爛，幾乎失明。台灣高等法院昨依業務過失重傷害罪判蔡五月徒刑，得易科罰金十三萬五千元確定。</span></strong> </span></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span style="FONT-SIZE:18pt;FONT-FAMILY:新細明體;">醫療糾紛<span lang="EN-US"></span></span></strong></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span style="FONT-FAMILY:新細明體;"><font size="3">藍</font><span lang="EN-US"><font size="3">xx的小姑得知判決結果，直呼：「判太輕了！四年多來，蔡XX對我們不理不睬，不但沒賠償半毛錢，連一句抱歉也沒有。<strong><span style="COLOR:fuchsia;">」蔡xx則說：「非常意外！<u>衛生</u>署、中華民國眼科學會的鑑定報告都說我沒疏失，法官卻判有罪，我無法接受。」 </span></strong><br>藍素香原本從事美髮工作，二○○五年十月間，她因<strong><span style="COLOR:fuchsia;">睡前忘記取下隱形眼鏡</span></strong>，早上醒來發現眼鏡拔不下來，到宜蘭市求助蔡xx醫師；藍女出庭控訴，當天她明白告訴蔡醫師及護士：「我的兩隻眼睛很痛，隱形眼鏡我自己拿不出來，請醫生幫我拿出來。」蔡醫師卻只用手撐開眼皮，用眼底鏡光束照射眼部，就告訴她：「應該是結膜炎。」只開眼藥，就要她離去。 </font></span></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span style="FONT-SIZE:18pt;FONT-FAMILY:新細明體;">民事判賠九十八萬<span lang="EN-US"></span></span></strong></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span style="FONT-FAMILY:新細明體;"><font size="3">藍女回家後雙眼仍刺痛難耐，打電話回診所確認時，護士還說醫師已幫她拔掉隱形眼鏡，<strong><span style="COLOR:fuchsia;">直到晚間藍女改到羅東博愛醫院求診，醫師用撐眼器撐開右眼皮，隱形眼鏡立刻彈出，才知隱形眼鏡根本沒取下，但藍女雙眼已因缺氧過久，導致角膜水腫、破皮，</span></strong>且受綠膿桿菌、黴菌感染而潰爛，視力僅剩零點零一，幾近失明。事後藍女進行兩次角膜移植手術，才在今年七月恢復視力。</font><span lang="EN-US"><br><font size="3">蔡XX辯稱<strong><span style="COLOR:fuchsia;">藍女沒將隱形眼鏡洗<u>乾淨</u>才會感染，</span></strong>但<strong><span style="COLOR:blue;">法官認定蔡若即時幫藍女拔下眼鏡，她的眼角膜就不會因破皮而被感染，</span></strong>因此判決蔡確有疏失。民事部分宜蘭地院上月判決蔡xx賠償九十八萬餘元，目前案件已上訴二審。 </font></span></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><font size="3"></font></span>&nbsp;</p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US"><font style="BACKGROUND-COLOR:#ffff00;" face="Times New Roman" size="3">EYE-DR: </font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span style="FONT-SIZE:9.5pt;COLOR:red;FONT-FAMILY:新細明體;"><font style="BACKGROUND-COLOR:#ffff00;">過失重傷害 強調 需有 絕對之因果關係<span lang="EN-US">, </span></font></span></strong></p>
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-SIZE:9.5pt;COLOR:red;FONT-FAMILY:新細明體;"><font style="BACKGROUND-COLOR:#ffff00;"></font></span></strong>&nbsp;</p>
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span style="FONT-SIZE:9.5pt;COLOR:red;FONT-FAMILY:新細明體;"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"></span></font></span></strong>&nbsp;</p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">醫療糾紛之刑事責任</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><u><span lang="EN-US"><font face="Times New Roman">1</font></span></u><u><span style="FONT-FAMILY:新細明體;">、普通過失與業務過失致傷害罪（刑法第二八四條）</span><span lang="EN-US"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">因過失傷害人者，處六月以下有期徒刑、拘役或五百元以下罰</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">金。</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman">2</font></span><span style="FONT-FAMILY:新細明體;">、普通過失與業務過失致死罪（刑法第二七六條）</span><span lang="EN-US"><font face="Times New Roman"> </font></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">因過失致人於死者，處二年以下有期徒刑、拘役或二千元以下</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">罰金。</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman">3</font></span><span style="FONT-FAMILY:新細明體;">、<u>過失犯之論證體系</u></span><u><span lang="EN-US"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><u><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">一、構成要件該當性</span><span lang="EN-US"></span></font></font></u></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font style="BACKGROUND-COLOR:#ffff00;"><u><span lang="EN-US"><font face="Times New Roman"><font size="3"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1)</font></font></span></u><font size="3"><u><span style="FONT-FAMILY:新細明體;">行為</span><span lang="EN-US"><font face="Times New Roman">------</font></span></u><u><span style="FONT-FAMILY:新細明體;">因果關係</span><span lang="EN-US"><font face="Times New Roman">------</font></span></u><u><span style="FONT-FAMILY:新細明體;">結果</span><span lang="EN-US"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><u><span lang="EN-US"><font face="Times New Roman"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2)</font></span></u><u><span style="FONT-FAMILY:新細明體;">過失：違背客觀必要注意義務</span><span lang="EN-US"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><u><span>&nbsp;</span></u></font></span><u><span style="FONT-FAMILY:新細明體;">結果有預見的可能時，違反結果預見義務（無認識過失）</span><span lang="EN-US"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><strong><u><span style="COLOR:red;"><span>&nbsp;</span></span></u></strong></font></span><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">已預見結果可能發生，且結果有迴避的可能時，違反結果迴</span><span lang="EN-US" style="COLOR:red;"></span></u></strong></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><strong><u><span lang="EN-US" style="COLOR:red;"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span></u></strong><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">避義務（有認識過失）</span><span lang="EN-US" style="COLOR:red;"></span></u></strong></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">二、違法性</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1)</font></span><span style="FONT-FAMILY:新細明體;">無阻卻違法事由</span><span lang="EN-US"><font face="Times New Roman"><span>&nbsp;&nbsp; </span>a.</font></span><span style="FONT-FAMILY:新細明體;">無法定阻卻違法與超法規阻卻違法事由</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">三、有責性</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1)</font></span><span style="FONT-FAMILY:新細明體;">無阻卻責任事由</span><span lang="EN-US"><font face="Times New Roman"><span>&nbsp;&nbsp; </span></font></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>a.</font></span><span style="FONT-FAMILY:新細明體;">行為人具備履行客觀注意義務要求之能力</span><span lang="EN-US"><font face="Times New Roman"><span>&nbsp;&nbsp; </span>b.</font></span><span style="FONT-FAMILY:新細明體;">期待可能性</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman">4</font></span><span style="FONT-FAMILY:新細明體;">、因果關係理論</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">因果關係：</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">相當因果關係</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">每一事件，依一般生活經驗（亦即事情之通常過程），適足以</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">造成一定之結果者。</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">疫學因果關係（藥害事件之因果關係）</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman"><font size="3"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><u><span>&nbsp;</span></u></font></font></span><u><font size="3"><span style="FONT-FAMILY:新細明體;">原因（因子）須於<span style="COLOR:red;">疾病結果發生之前即已存在一段期間</span></span><span lang="EN-US" style="COLOR:red;"></span></font></u></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><u><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span></u><u><span style="FONT-FAMILY:新細明體;">原因（因子）作用愈顯著，疾病之罹患率愈高</span><span lang="EN-US"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">原因（因子）除去後，疾病罹患率減低或消失</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman">5</font></span><span style="FONT-FAMILY:新細明體;">、過失</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman"><span>&nbsp; </span><u><span>&nbsp;</span></u></font></span><u><span style="FONT-FAMILY:新細明體;">過失：違反客觀必要注意義務</span><span lang="EN-US"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman"><span>&nbsp; </span><strong><span style="COLOR:red;"><span>&nbsp;</span></span></strong></font></span><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">結果預見可能──則違反結果預見義務為過失</span><span lang="EN-US" style="COLOR:red;"></span></u></strong></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font style="BACKGROUND-COLOR:#ffff00;"><font face="Times New Roman"><span lang="EN-US"><span><font size="3">&nbsp;</font></span></span><span lang="EN-US" style="FONT-SIZE:11pt;"><span>&nbsp; </span></span></font><strong><u><span style="FONT-SIZE:11pt;COLOR:red;FONT-FAMILY:新細明體;">結果迴避可能──則違反結果迴避義務為過失</span></u></strong><strong><u><span lang="EN-US" style="FONT-SIZE:11pt;COLOR:red;"></span></u></strong></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="Times New Roman"><font style="BACKGROUND-COLOR:#ffff00;"><span>&nbsp; </span></font></font></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman">6</font></span><span style="FONT-FAMILY:新細明體;">、<u><span style="COLOR:red;">醫師是否已盡結果預見義務與結果迴避義務之判斷標準</span></u></span><u><span lang="EN-US" style="COLOR:red;"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><u><span lang="EN-US" style="COLOR:red;"><span><font face="Times New Roman">&nbsp;&nbsp; </font></span></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">以「一般醫師」之標準判斷之</span><span lang="EN-US" style="COLOR:red;"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">即一般醫師之平均水準判斷，又稱<u><span style="COLOR:red;">「醫療專業水準」，簡稱「醫療水準」（</span></u></span><u><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">medical standard</font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">）</span><span lang="EN-US" style="COLOR:red;"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">意即一般醫師之醫療水準能預見結果之發生，而行為醫師竟因疏忽而無預見，或雖有預見，但一般醫師之醫療水準能迴避該結果</span><span lang="EN-US"><span><font face="Times New Roman">&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">之發生，而行為醫師因疏忽而無法阻止結果之發生，此乃醫療過失。</span><span lang="EN-US"></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">反過來說<strong><u><span style="COLOR:red;">，一般醫師無法預見或無法迴避結果之發生，行為醫師未預見或未能迴避結果發生，則無過失。</span></u></strong></span><strong><u><span lang="EN-US" style="COLOR:red;"></span></u></strong></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US"><font style="BACKGROUND-COLOR:#ffff00;" face="Times New Roman" size="3"></font></span>&nbsp;</p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><font face="Times New Roman">7</font></span><span style="FONT-FAMILY:新細明體;">、<strong><u><span style="COLOR:red;">醫療水準（</span></u></strong></span><strong><u><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">medical standard</font></span></u></strong><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">）</span><span lang="EN-US" style="COLOR:red;"></span></u></strong></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><strong><u><span lang="EN-US" style="COLOR:red;"><span><font face="Times New Roman">&nbsp;&nbsp; </font></span></span></u></strong><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">醫療上注意義務（結果預見義務</span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u></strong><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">與</span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u></strong><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">結果迴避義務）標準乃</span><span lang="EN-US" style="COLOR:red;"></span></u></strong></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span lang="EN-US"><span><font face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">實務上判斷醫師是否已盡一般醫療水準所要求之預見與迴避義務，主要由法官依<strong><u><span style="COLOR:red;">衛生署醫事審議委員會之鑑定報告</span></u></strong>（是否合於醫療一般做法，即一般醫療水準）判斷之。</span></font></font></p>
<div style="BORDER-RIGHT:medium none;PADDING-RIGHT:0pt;BORDER-TOP:medium none;PADDING-LEFT:0pt;PADDING-BOTTOM:1pt;BORDER-LEFT:medium none;PADDING-TOP:0pt;BORDER-BOTTOM:windowtext 2.25pt double;">
<p class="MsoNormal" style="BORDER-RIGHT:medium none;PADDING-RIGHT:0pt;BORDER-TOP:medium none;PADDING-LEFT:0pt;PADDING-BOTTOM:0pt;MARGIN:0pt;BORDER-LEFT:medium none;PADDING-TOP:0pt;BORDER-BOTTOM:medium none;"><span lang="EN-US"><font style="BACKGROUND-COLOR:#ffff00;" face="Times New Roman" size="3"></font></span>&nbsp;</p>
</div>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">依因果關係理論</span><span lang="EN-US"><font face="Times New Roman">: </font></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">此案例</span><span lang="EN-US"><font face="Times New Roman">:<span>&nbsp; </span></font></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><u><span style="FONT-FAMILY:新細明體;">原因（因子）</span><span lang="EN-US"><font face="Times New Roman">:</font></span></u><u><span style="FONT-FAMILY:新細明體;">於<span style="COLOR:red;">疾病結果發生之前</span></span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">即已存在一段期間</span><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">, </font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">如隱形眼鏡配戴過久</span><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">,<span>&nbsp; </span></font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">隱形眼鏡清潔劑未定期更換</span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u><span style="FONT-FAMILY:新細明體;">。</span><u><span lang="EN-US" style="COLOR:red;"></span></u></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">果</span><span lang="EN-US"><font face="Times New Roman">:<span>&nbsp; </span></font></span><span style="FONT-FAMILY:新細明體;">造成</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">角膜潰瘍</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">而</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">失明</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">。</span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">是否</span><span lang="EN-US"><span><font face="Times New Roman">&nbsp; </font></span></span><u><span style="FONT-FAMILY:新細明體;">原因（因子）</span><font face="Times New Roman"> <span lang="EN-US">“</span></font></u><span lang="EN-US"><font face="Times New Roman"> </font></span><u><span style="COLOR:red;FONT-FAMILY:新細明體;">隱形眼鏡</span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">提早拔除</span><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">”<span>&nbsp; </span>, </font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">完全不會造成</span><span lang="EN-US" style="COLOR:red;"><span><font face="Times New Roman">&nbsp; </font></span></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">結</span></u><span style="FONT-FAMILY:新細明體;">果</span><span lang="EN-US"><font face="Times New Roman">: “</font></span><span style="FONT-FAMILY:新細明體;">角膜潰瘍</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">而</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">失明</span><font face="Times New Roman"> <span lang="EN-US">“<span>&nbsp; </span>, </span></font><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">衛生署醫事審議委員會之鑑定報告</span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u></strong><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">已</span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u></strong><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">說明的十分清楚</span></u></strong><span style="FONT-FAMILY:新細明體;">。</span><strong><u><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman"> </font></span></u></strong></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">此案例</span><span lang="EN-US"><font face="Times New Roman">:<span>&nbsp; </span></font></span><span style="FONT-FAMILY:新細明體;">依</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">以往</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">法院之判例</span><span lang="EN-US"><font face="Times New Roman"> , </font></span><span style="FONT-FAMILY:新細明體;">頂多</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">判定</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">檢查之</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">延遲</span><span lang="EN-US"><font face="Times New Roman"> , </font></span><span style="FONT-FAMILY:新細明體;">如果依</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">絕對之因果關係</span><span lang="EN-US"><font face="Times New Roman"> , </font></span><span style="FONT-FAMILY:新細明體;">判定</span><span lang="EN-US"><span><font face="Times New Roman">&nbsp; </font></span></span><span style="FONT-FAMILY:新細明體;">蔡</span><span lang="EN-US"><font face="Times New Roman"> xx </font></span><span style="FONT-FAMILY:新細明體;">醫師</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">有</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">絕對之</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">刑事責任</span><span lang="EN-US"><font face="Times New Roman">, </font></span><span style="FONT-FAMILY:新細明體;">相信</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">學過基本法律者</span><span lang="EN-US"><font face="Times New Roman">, </font></span><span style="FONT-FAMILY:新細明體;">皆不予茍同。</span><span lang="EN-US"><font face="Times New Roman"> </font></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">此案例</span><span lang="EN-US"><font face="Times New Roman">:<span>&nbsp; </span></font></span><span style="FONT-FAMILY:新細明體;">檢察及法院體系</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">未</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">採信</span><font face="Times New Roman"> <span>&nbsp;</span></font><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">衛生署醫事審議委員會之鑑定報告</span><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">(</font></span></u></strong><strong><u><span style="COLOR:red;FONT-FAMILY:細明體;">行政院衛生署醫事審議委員會二次鑑定意見「即使醫師乙<span lang="EN-US">○○於初診時，及時發</span></span></u></strong></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><strong><u><span lang="EN-US" style="COLOR:red;FONT-FAMILY:細明體;"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>現並取出病人雙眼之隱形眼鏡，並不能避免事後演變為黴菌感染。) </span></u></strong><strong><u><span style="COLOR:red;FONT-FAMILY:新細明體;">即</span></u></strong><span style="FONT-FAMILY:新細明體;">檢察及法院體系</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">推翻了</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">一般醫療水準所要求</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">的標準</span><span lang="EN-US"><font face="Times New Roman">, </font></span><span style="FONT-FAMILY:新細明體;">力圖</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">將</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">所有</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">診所的</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">治療水準提升至</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">醫學中心級</span><span lang="EN-US"><font face="Times New Roman"> ,<span>&nbsp; </span></font></span><span style="FONT-FAMILY:新細明體;">試問</span><span lang="EN-US"><font face="Times New Roman">: </font></span><span style="FONT-FAMILY:新細明體;">一天看</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">數百位</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">急性結膜炎</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">的</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">診所醫師</span><span lang="EN-US"><font face="Times New Roman">, </font></span><span style="FONT-FAMILY:新細明體;">會每位案例</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">皆用</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">細隙燈看嗎</span><span lang="EN-US"><font face="Times New Roman">?<span>&nbsp; </span></font></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">此案例</span><span lang="EN-US"><font face="Times New Roman">: </font></span><span style="FONT-FAMILY:新細明體;">法官一直很主觀的認知</span><span lang="EN-US"><font face="Times New Roman">: “</font></span><u><span style="COLOR:red;FONT-FAMILY:新細明體;">隱形眼鏡</span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">提早拔除</span><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">”<span>&nbsp; </span>, </font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">完全不會造成</span><span lang="EN-US" style="COLOR:red;"><span><font face="Times New Roman">&nbsp; </font></span></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">結</span></u><span style="FONT-FAMILY:新細明體;">果</span><span lang="EN-US"><font face="Times New Roman">: “</font></span><span style="FONT-FAMILY:新細明體;">角膜潰瘍</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">而</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">失明</span><font face="Times New Roman"> <span lang="EN-US">“</span></font><span style="FONT-FAMILY:新細明體;">。</span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">其實</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">這是不可能的事</span><span lang="EN-US"><font face="Times New Roman">! </font></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">臨床上</span><span lang="EN-US"><font face="Times New Roman"> , </font></span><span style="FONT-FAMILY:新細明體;">有治療性<u><span style="COLOR:red;">隱形眼鏡</span></u></span><u><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman"> ,<span>&nbsp; </span></font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">會讓病患戴個兩</span></u><u><span style="COLOR:red;FONT-FAMILY:標楷體;">、</span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">三天</span><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">,<span>&nbsp; </span></font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">以幫助</span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">角膜</span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">破皮癒合</span><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">, </font></span></u><span style="FONT-FAMILY:新細明體;">。</span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><u><span style="COLOR:red;FONT-FAMILY:新細明體;">因此</span><span style="COLOR:red;"><font face="Times New Roman"> </font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">此案例的重點是</span></u><span style="FONT-FAMILY:新細明體;">角膜潰瘍</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">是因為</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">感染</span><span lang="EN-US"><font face="Times New Roman">(</font></span><span style="FONT-FAMILY:新細明體;">原因很多</span><span lang="EN-US"><font face="Times New Roman">…..) ,<span>&nbsp; </span></font></span><u><span style="COLOR:red;FONT-FAMILY:新細明體;">隱形眼鏡</span><span lang="EN-US" style="COLOR:red;"><span><font face="Times New Roman">&nbsp; </font></span></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">是否提早拔除</span><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">, </font></span></u><u><span style="COLOR:red;FONT-FAMILY:新細明體;">倒是其次</span><span lang="EN-US" style="COLOR:red;"><font face="Times New Roman">,</font></span></u><span lang="EN-US"><font face="Times New Roman"> </font></span><span style="FONT-FAMILY:新細明體;">。</span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">此案例</span><span lang="EN-US"><font face="Times New Roman">:<span>&nbsp; </span></font></span><span style="FONT-FAMILY:新細明體;">一旦形成</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">典型之有罪刑事判例後</span><font face="Times New Roman"> <span lang="EN-US">, </span></font><span style="FONT-FAMILY:新細明體;">醫師檢查之</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">延遲</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">皆須受刑事判決</span><span lang="EN-US"><font face="Times New Roman"> , </font></span></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font size="3"><font style="BACKGROUND-COLOR:#ffff00;"><span style="FONT-FAMILY:新細明體;">這真是</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">法</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">界</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">奇</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">蹟</span><span lang="EN-US"><font face="Times New Roman">! <span>&nbsp;</span><span>&nbsp;</span></font></span><span style="FONT-FAMILY:新細明體;">醫</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">界</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">之</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">悲</span><font face="Times New Roman"> </font><span style="FONT-FAMILY:新細明體;">哀</span><font face="Times New Roman"> </font></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US"><font face="Times New Roman" size="3"></font></span>&nbsp;</p>
<span lang="EN-US">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><font size="3"></font></span>&nbsp;</p>
<p class="MsoNormal" style="MARGIN:0pt;"><span style="FONT-FAMILY:新細明體;"><font size="3">轉貼 法院判決文<span lang="EN-US">: </span></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US"><font face="Times New Roman" size="3"></font></span>&nbsp;</p>
<span lang="EN-US">
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">裁判字號】<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">97,醫易,1</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">【裁判日期】<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">980526</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">【裁判案由】<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">過失重傷害<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">【裁判全文】<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">?</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">臺灣宜蘭地方法院刑事判決　　　　　　　<span lang="EN-US"> 97年度醫易字第1號</span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">公　訴　人　臺灣宜蘭地方法院檢察署檢察官<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">被　　　告　乙○○<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">選任辯護人　吳振東律師<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">上列被告因過失重傷害案件，經檢察官提起公訴（<span lang="EN-US">95年度偵字第</span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">4442號），本院判決如下：</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>主<span>&nbsp; </span>文</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">乙○○犯業務過失致人重傷害罪，處有期徒刑拾月，減為有期徒<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">刑伍月，如易科罰金，以銀元參佰元即新臺幣玖佰元折算壹日。<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>事<span>&nbsp; </span>實</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">一、乙○○於宜蘭縣宜蘭市○○路○段<span lang="EN-US">113號開設「乙○○眼科診</span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>所」並擔任眼科醫師，以幫患者治療眼疾為業，為從事眼科</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>醫療業務之人。戊○○於民國94年10月17日下午配戴隱形眼</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>鏡後，忘了取出隱形眼鏡即入睡，至94年10月18日上午6時</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>許醒來，發現雙眼乾澀、疼痛，無法自行取出隱形眼鏡，遂</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>於當日早上由家人林文達陪同前往「乙○○眼科診所」診所</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>求診，並由乙○○為其看診，乙○○於診療戊○○之過程中</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>，依其身為眼科專業醫師之智識程度及醫療經驗，本應注意</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>仔細聽聞戊○○主訴之內容，且於戊○○主訴「我的眼睛很</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>痛，我的隱形眼鏡拿不下來，請醫師幫忙拿」後，更應使用</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>「撐眼器」等輔助工具，仔細檢查戊○○之雙眼內是否有隱</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>形眼鏡且將之取出，然依當時乙○○看診之情形及為患者取</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>出眼內隱形眼鏡並非難度高之醫療行為，乙○○顯並無不能</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>注意之情事，詎乙○○竟疏未注意仔細聽聞戊○○主訴「我</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>的眼睛很痛，我的隱形眼鏡拿不下來，請醫師幫忙拿」之內</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>容，且疏於使用「撐眼器」等輔助工具仔細檢查戊○○雙眼</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>內是否有隱形眼鏡未取出，僅用手撐開戊○○之雙眼，以眼</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>底鏡光束照射查看後，即草率判定戊○○係急性結膜炎，遂</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>於幫戊○○點麻藥等藥水舒緩其疼痛不適之感覺後，即告知</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>戊○○「已經處理好了，這兩天還會痛，明天再來回診」等</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>語，戊○○因疼痛不適之情形減緩，認為乙○○已將其眼內</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>之隱形眼鏡取出，即拿著乙○○所開立之消炎用眼藥水返家</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>。迨至94年10月18日下午，戊○○因雙眼疼痛仍未稍緩解，</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>其家屬林文斌去電診所詢問是否確已將隱形眼鏡取出，經該</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>診所護士轉詢乙○○後，僅覆稱要其隔日再行回診，然戊○</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>○因疼痛難當，遂於94年10月18日晚間前往財團法人羅許基</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>金會羅東博愛醫院（下稱博愛醫院）就診，由丙○○醫師為</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>其診治，於點妥眼用麻藥，甫撐開戊○○右眼之際，即有隱</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>形眼鏡自戊○○之右眼彈出，丙○○繼以「撐眼器」撐開戊</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>○○左眼，並輔以「隙細燈」詳細檢視，果發現確有隱形眼</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>鏡在戊○○左眼內，旋以鑷夾將之取出，惟此時戊○○之雙</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>眼已因隱形眼鏡在眼內過久，未及時取出，以致受有雙眼角</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>膜水腫、角膜上皮大面積脫落缺損之傷害，更因其保護角膜</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>對抗外界病菌防止角膜受傷害之重要組織「角膜表皮」已經</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>有大面積的脫落受傷，導致其雙眼因而受到綠膿桿菌、黴菌</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>之侵襲感染而受有雙眼角膜潰瘍之傷害，雖戊○○自94年10</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>月18日晚間起迄94年10至21日陸續於博愛醫院接受治療，且</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>自94年10月22日起轉往國立臺灣大學醫學院附設醫院（下稱</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>台大醫院）接受治療，然最終仍因雙眼角膜潰瘍之傷勢過重</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>，導致其雙眼視力均小於0.01，已無法以光學矯正治癒，需</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>施行角膜移植手術，而成雙眼視力喪失之重傷害結果。</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">二、案經戊○○訴由臺灣宜蘭地方法院檢察署檢察官偵查起訴。<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>理<span>&nbsp; </span>由</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">一、按被告以外之人於審判外之言詞或書面陳述，除法律有規定<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>者外，不得作為證據。又被告以外之人於審判外之陳述，雖</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>不符前四條之規定，而經當事人於審判程序同意作為證據，</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>法院審酌該言詞陳述或書面陳述作成時之情況，認為適當者</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>，亦得為證據。當事人、代理人或辯護人於法院調查證據時</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>，知有第159條第1項不得為證據之情形，而未於言詞辯論終</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>結前聲明異議者，視為有前項之同意，刑事訴訟法第159條</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>第1項、第159條之5第1項、第2項分別定有明文。本件情形</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>，被告、辯護人、檢察官於本院審理時對於下列所述之證據</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>資料，均不爭執其證據能力，本院審酌該等證據資料作成時</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>之狀況，均無不宜作為證據情事，依刑事訴訟法第159條之5</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>第2項規定，自均得作為證據。</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">二、訊據被告乙○○固不否認「伊於宜蘭縣宜蘭市○○路○段<span lang="EN-US">113</span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>號開設乙○○眼科診所，擔任眼科醫師，從事眼科醫療之業</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>務。94年10月18日早上戊○○曾到診所來就診，由伊為戊○</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>○看診，戊○○表示眼睛很痛，伊只有用手撐開戊○○的眼</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>睛，為戊○○點眼藥水、將眼睛的分泌物清除，使用眼底鏡</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>的光束照戊○○的眼睛，針對以手撐開所看得到眼睛部位加</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>以檢查，以伊當時所見之範圍，伊並沒有見到戊○○的眼睛</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>內有異物，且檢查後亦確定戊○○並無眼角膜破皮、眼角膜</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>水腫、眼角膜上皮脫落或角膜潰瘍之情形，故伊認為戊○○</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>的眼睛是因為隱形眼鏡沒有清洗乾淨所引發的急性結膜炎，</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>便開立消炎用的眼藥水給戊○○。當天下午，戊○○之家屬</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>曾打電話來診所表示戊○○的眼睛還在痛，當時伊還在手術</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>中，便請門診護士轉告戊○○的家屬，請戊○○再回來看診</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>。嗣後戊○○到博愛醫院、台大醫院就診後，因雙眼角膜潰</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>瘍及黴菌感染，已呈現雙眼視力均小於0.01，無法以光學矯</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>正，須施行角膜移植手術之情形。」等情（見本院卷第26、</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>29、207、208、211、212頁），惟矢口否認有何業務過失致</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>重傷害之犯行，辯稱「94年10月18日早上戊○○到診所看診</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>時，只有說她的眼睛痛，戊○○並沒有說她是因為隱形眼鏡</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>隔夜沒有取出而眼睛不舒服，她並沒有要求我幫她將隱形眼</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>鏡拿出來。戊○○所受之傷勢與我的診療行為無關，我沒有</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp; </span>檢察官所起訴的業務過失致重傷害犯行。」云云，然查：</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">（一）上揭犯罪事實，已據證人即被害人戊○○於檢察官偵訊及<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>本院審理時指訴綦詳（見宜蘭地檢署95年度他字第416號</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>卷第109至110頁，本院卷第55至73頁），核與證人即戊○</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>○家屬林文達於檢察官偵訊時證述「94年10月18日早上，</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>戊○○說他的眼睛不舒服，隱形眼鏡忘了取出，我就陪戊</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>○○前往『乙○○眼科診所』就醫，我曾聽見診所之護士</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>詢問戊○○是什麼狀況，戊○○對護士說她的隱形眼鏡無</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>法拿下來，護士說那就不用驗光，等醫生直接看就可以。</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3">&lt;font face=&quot;</font></span></p>
</span></span>]]></description>
            <pubDate>Sat, 31 Oct 2009 01:18:45 +0800</pubDate>
            <guid><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4464]]></guid>
         </item>         <item>
            <title><![CDATA[年齡的秘密！？]]></title>
            <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4463]]></link>
            <description><![CDATA[<table class="text" style="TABLE-LAYOUT:fixed;WORD-BREAK:break-all;" cellSpacing="0" cellPadding="0" width="100%" align="center" border="0">
<tbody>
<tr>
<td class="title"><strong>2009年年齡的秘密！？</strong></td></tr>
<tr>
<td>
<table cellSpacing="1" cellPadding="2" width="320" align="left" border="0">
<tbody>
<tr>
<td bgColor="#efefef"></td></tr>
<tr>
<td class="sub-b" bgColor="#efefef"><span id="img_desc">傳說2009年年齡有個秘密，只要從0~9選一個數字，代入網路流傳的神奇公式，就能猜中你的年齡！猜猜圖中的「34F珊瑚礁女孩」今年幾歲？</span> </td></tr></tbody></table>
<p class="news" align="left"><br>你知道2009年年齡的秘密嗎？網路流傳一個神奇的公式，玩家只要先選出0~9任一個數字，按照步驟加減乘除，再扣掉自己的西元出生年份，最後得到的三位數就會顯示你的年齡跟最初選的數字！究竟這個有趣的年齡秘密，是怎麼一回事？ <br><br>看原信：<a href="http://examine.nownews.com/examine_detail.php?eid=5392">超準!!關於年齡的秘密---2009年年齡的秘密</a> <br><br>年齡可是女人的秘密，如果不小心在遊戲中被破解出來，那就不好玩啦！為了捍衛廣大的女性讀者免於「受騙」，追追追小組就帶大家來分析原理。首先複習一下原信的神奇公式跟答案： <br><br><strong>公式：</strong> <br><font color="#007afa">[1] 首先 ,隨意挑一個數字( 0.1.2 .3.4.5.6.7.8.9) <br>[2] 把這個數字?乘上2 <br>[3] 然後?加上 5 <br>[4] 再乘以 50 <br>[5]把得到的數目 加上1759 <br>[6]最後一個步驟，用這個數目減去你出生的那一年 (西元的) </font></p>
<p><font color="#007afa"></font>&nbsp;</p>
<p><font color="#007afa">代數解:</font><br><br><strong>答案：</strong> <br><font color="#007afa">三位數的數字，第一個位數：是你一開始選擇的數目，接下來的二個位數：就是你的年齡</font> <br><br>再來，利用國中數學「二元一次方程式」的概念進行分析，假設步驟1的任意數字為X，步驟6的西元出生年份為Y，答案裡的年齡為Z，寫成方程式就變成： <br><br><font color="#007afa">( 2X + 5 ) × 50 + 1759 – Y = 100X + Z </font><br><br>將等號前面的算式化開，可以發現結果等於「數字X乘以100」加「2009（年）減去出生年份Y」，前者因為乘以100，所以不論選哪個數字，都會跑到百位數；後者因為用2009年去減出生年份，所以一定能算出年齡。 <br><br>( 2X + 5 ) × 50 + 1759 – Y <br>= 100X + 250 + 1759 – Y <br>= 100X + 2009 – Y <br>= ( 100X ) + ( 2009 – Y ) <br>= 100X + Z <br></p>
</td></tr></tbody></table>]]></description>
            <pubDate>Fri, 30 Oct 2009 00:20:50 +0800</pubDate>
            <guid><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4463]]></guid>
         </item>         <item>
            <title><![CDATA[評論: 美牛風暴 馬總統點名楊志良負責]]></title>
            <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4460]]></link>
            <description><![CDATA[<div class="story_title" id="story_title" style="FLOAT:left;">美牛風暴 馬總統點名楊志良負責</div>
<div style="FLOAT:right;"></div>
<p>&nbsp;</p>
<table cellSpacing="3" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td width="130%"><img height="1" src="http://udn.com/1024/images/linedot.gif" width="1"/></td></tr>
<tr>
<td>
<table cellSpacing="0" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td class="story_author" width="75%">
<div id="story_author">【聯合報╱記者李明賢／台北報導】</div></td>
<td class="story_author" width="25%">
<div id="story_update" align="right">2009.10.28 06:03 am</div></td></tr></tbody></table></td></tr>
<tr>
<td class="story_author">&nbsp;</td></tr>
<tr>
<td vAlign="top">
<div class="story" id="story">
<p>開放進口美國牛引發政治風暴，馬英九總統昨天接受新新聞雜誌專訪時點名衛生署長楊志良要負責。他透露，周日政府機關曾開全天會議，把大家說法定調，周一楊志良等首長前往立法院說明，「但政府在第一時間說得不夠清楚，造成大家一些誤解，這點確實該檢討」。 
<p>對於楊志良在第一時間對談判結果表示意外，馬總統也表示，站在衛生署立場，能把風險較大的排除掉最好，譬如說內臟，也許他有這種想法，「但我們聽的簡報都是他做的啊，不然我怎麼會懂這個東西？」 
<p>...............................................................&nbsp; 
<p>======================================================</p>
<p>Eye-Dr: </p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <font color="#0000ff"><strong>只看簡報的總統 , </strong></font></p>
<p><font color="#0000ff"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 是有點...................</strong></font></p>
<p><font color="#0000ff"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;美國牛的問題 ,</strong></font></p>
<p><font color="#0000ff"><strong>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;早就不是風險問題 ,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></font></p>
<p><font color="#0000ff"><strong>&nbsp;&nbsp;&nbsp; &nbsp;而是 政治 問題 !</strong></font></p>
<p><font color="#0000ff"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 政府官員 老是 少一根筋吧!</strong></font></p>
<p><strong><font color="#0000ff">&nbsp;&nbsp;&nbsp;&nbsp; </font></strong></p>
</div></td></tr></tbody></table>]]></description>
            <pubDate>Wed, 28 Oct 2009 15:57:19 +0800</pubDate>
            <guid><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4460]]></guid>
         </item>         <item>
            <title><![CDATA[轉貼: 望子成龍，子不成龍]]></title>
            <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4456]]></link>
            <description><![CDATA[<img src="http://tw.blog.yahoo.com/photo/photo.php?id=HSPM5qCVERshgArt8Sfx&amp;photo=tn_F23_20091028122824201.jpg"/><br>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">轉貼<span lang="EN-US">: 望子成龍，子不成龍</span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">/ 李家同</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">【聯合報╱李家同／暨南、清華、靜宜大學榮譽教授（新竹市）】<span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">2009.10.28 </font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">最近，我們國家發生了一起令人啼笑皆非的事：有一些望子成龍的家長，將孩子送進了一家號稱可以幫助孩子心智開發的補習班，這個補習班居然叫孩子吞火，鬧成了社會新聞。除了這則新聞以外，我們又發現很多家長帶孩子去檢測皮紋，在我看來，這等於看手相，可以說是可笑之至，但為什麼有這麼多家長信這些玩意兒？還不又是希望看到自己孩子將來能夠非常地出人頭地。 <span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">這種望子成龍的想法，並非只有台灣才有，大陸的孩子一樣可憐，因為一大堆的小孩子被迫去解一些數學上的難題，這些都是奧林匹亞的數學題目，昨天<strong><span style="COLOR:fuchsia;">聯合報公布了一個難題，你如果是小學生，你一定不會，但你如果學過代數，又一定會。</span></strong>我看了這個題目以後，利用代數，一下就解出來了。為什麼我們要如此地折磨孩子呢？<strong><font color="#ff007f">為什麼不等孩子學會代數再給他這個題目呢？我們不是希望孩子有信心嗎？</font><font color="#0080ff">給小學生這種題目，有點像叫高中生發明微積分。大陸這種給小孩子難題做的事情終於成了大新聞，也迫使成都政府嚴禁奧數。</font></strong>我們這裡也許情形沒有那麼嚴重，但是我就看到好多小學生完全不會做的數學題目。對於絕大多數的小學生而言，這種題目的唯一作用是使他們害怕數學。 <span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">………………我們家長和老師，都不該對孩子們期望過高，我們只要孩子們在功課上有基本的能力，就應該心滿意足矣。對孩子有太高的期望，絕對害了孩子，即使他很聰明，也可能因為過高的壓力反而失去了信心。 </font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">不知何故，我們對「成功」看得太重了，坊間充滿了如何成功的書，也難怪家長們個個摩拳擦掌，要將自己的孩子培養成下一個比爾蓋玆或下一個郭台銘。要到達這個境界，必須從小就開發他的心智。難怪有的孩子要被迫吞火，有的要被迫做數學難題，更有些小嬰兒從小就被迫讀英文詩。 <span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">望子成龍，是不好的事，家長們都應該知道這一點，因為孩子極可能有一種被扭曲的價值觀。我曾經看過一個小學生，因為國文作業（並非考試）得了八十六分而痛哭不止。後來我終於說服了孩子的家長不要太關心孩子的分數。果真，孩子不會因為分數差一點而痛苦不堪。如果孩子的父母一直希望他必須考到九十分的話，他極可能已放棄唸書了。 <span lang="EN-US"></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">【<span lang="EN-US">2009/10/28 聯合報】</span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span lang="EN-US"></span></font></font></span>&nbsp;</p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span lang="EN-US"></span></font></font></span>&nbsp;</p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span lang="EN-US">Eye-Dr:</span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span>&nbsp;</p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">代數解<span lang="EN-US">: </span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">小偉速度<span lang="EN-US">= X ,小強速度= Y</span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">Y= X+160 </font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">X x (5+10) + Y x 10 = 3550</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">15 X + 10 X + 1600 = 3550</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">X= 78 </font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span>&nbsp;</p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">我想現在<font color="#ff007f"><strong>小學數學教育最大的問題是, 大量的用 可簡單用代數解的題目, 去考倒不會使用 代數的小學生.&nbsp;</strong></font>&nbsp; &nbsp;</font></span><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">部編版的數學習作 更是嚴重 . </font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">也因此 我也有個疑問? </font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">小學生 為何不 早一點教 代數 ?</font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span>&nbsp;</p>]]></description>
            <pubDate>Wed, 28 Oct 2009 12:35:05 +0800</pubDate>
            <guid><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4456]]></guid>
         </item>         <item>
            <title><![CDATA[天啊! 人工水晶體變白了]]></title>
            <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4452]]></link>
            <description><![CDATA[<br><br>
<p>手術日期: 2003.07.&nbsp; Implant Acrysof 3-piece&nbsp; </p>
<p>IOL Glistening Grade IV</p>
<p><img src="http://tw.blog.yahoo.com/photo/photo.php?id=HSPM5qCVERshgArt8Sfx&amp;photo=tn_F23_20091027114842606.jpg"/></p>
<p>眼底 灰茫茫 一片 <br><img src="http://tw.blog.yahoo.com/photo/photo.php?id=HSPM5qCVERshgArt8Sfx&amp;photo=tn_F23_20091027114837702.jpg"/></p>
<p>病人視力由裸視 1.0 ,&nbsp; 降至近一個月的0.3,</p>
<p>老實的跟病人說,IOL 變質了 , </p>
<p>(他才 72歲......................)</p>
<p>預定 IOL EXPLANTATION&nbsp; AND CHANGE IOL</p>
<p>文獻參考:</p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"></span><font face="Times New Roman"><font color="#ff007f"><strong><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:AdvHVC;">J CATARACT REFRACT SURG - </span><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:AdvHVCBD;">VOL 35, NOVEMBER 2009</span></strong></font></font></p>
<p><img src="http://tw.blog.yahoo.com/photo/photo.php?id=HSPM5qCVERshgArt8Sfx&amp;photo=tn_F23_20091105124826694.jpg"/></p>
<p><img src="http://tw.blog.yahoo.com/photo/photo.php?id=HSPM5qCVERshgArt8Sfx&amp;photo=tn_F23_20091105124829883.jpg"/></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:9pt;FONT-FAMILY:Arial;"><font color="#ff007f"><strong>Whitening</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:Arial;"><font color="#ff007f"><strong>•Slight opacification of the IOL</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:Arial;"><font color="#ff007f"><strong>surface.</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:Arial;"><font color="#ff007f"><strong>•Numerous small water aggregates</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:Arial;"><font color="#ff007f"><strong>are visualized as the IOL surface</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:Arial;"><font color="#ff007f"><strong>causes opacification.</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:9pt;FONT-FAMILY:Arial;"><font color="#00bf60"><strong>Glistening</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:Arial;"><font color="#00bf60"><strong>•Bright spots (void) throughout the</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:Arial;"><font color="#00bf60"><strong>entire IOL optic.</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:Arial;"><font color="#00bf60"><strong>•Phase-separated water aggregates</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:Arial;"><font color="#00bf60"><strong>in the optic materials are relatively</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font color="#00bf60"><strong><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:Arial;">large and appear as voids.</span><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"></span></strong></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">To evaluate environmental factors promoting the</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">development of whitening, we examined air-dried</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">IOLs to evaluate opacification after water was removed</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">from the optic material. Surface opacification</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">of the extracted IOLs disappeared after the IOLs</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">were dried. Furthermore,<font color="#ff007f"><strong> opacification gradually</strong></font></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman" color="#ff007f"><strong>reappeared after further immersion in physiologic</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman"><font color="#ff007f"><strong>saline, increased over time, </strong></font>and finally reached the</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">degree seen before drying (just after extraction). Although</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">the IOL we studied was of a hydrophobic</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font face="Times New Roman"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;">material, it contains a small amount (</span><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvPS4731B1;">!</span><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;">1%) of water.</span><span lang="EN-US" style="FONT-SIZE:6.5pt;COLOR:#000066;FONT-FAMILY:AdvTT1dfd66bb;">6</span></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">When immersed in physiologic saline again after</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">drying, the optic material gradually regained this</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">water content and opacification reappeared. These</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">findings suggest that <font color="#ff007f"><strong>opacification (whitening) can</strong></font></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman" color="#ff007f"><strong>be caused by trace water molecules in the optic</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><font face="Times New Roman"><font color="#ff007f"><strong><span lang="EN-US" style="FONT-SIZE:10pt;COLOR:black;FONT-FAMILY:AdvTT1dfd66bb;">material.</span><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"></span></strong></font></font></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">However, during </font></span><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">longer term follow-up and <font color="#ff4040"><strong>with other high-performance</strong></font></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman" color="#ff4040"><strong>IOLs (eg, multifocal IOLs), many questions</strong></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman"><font color="#ff4040"><strong>about the effects of whitening remain unanswered</strong></font>.</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman"><font color="#0000ff"><strong>The ideal IOL would not have opacification</strong></font>. Efforts</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">must thus focus on designing IOL materials that retain</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">the benefits of hydrophobic soft acrylic but avoid opacification,</font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"><font face="Times New Roman">which may develop due to water content. </font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"></span>&nbsp;</p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:10pt;FONT-FAMILY:AdvTT1dfd66bb;"></span><font face="Times New Roman"><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:AdvHVC;">J CATARACT REFRACT SURG - </span><span lang="EN-US" style="FONT-SIZE:7pt;FONT-FAMILY:AdvHVCBD;">VOL 35, NOVEMBER 2009</span></font></p>
<p>
<p>FDA&nbsp; ADR REPORT</p>
<p>&nbsp;</p>
<div align="center">
<table class="MsoNormalTable" style="MARGIN:auto;WIDTH:102.14%;" cellSpacing="0" cellPadding="0" width="102%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="0%">
<p class="MsoNormal" style="MARGIN:0pt;">&nbsp;</p>
</td>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;BACKGROUND:#888888;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" colSpan="2">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="1" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:3.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:3.75pt;BACKGROUND:#e9e9e3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ffffff;WIDTH:100%;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ffffff;" vAlign="top" width="100%">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="3" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">ALCON LABORATORIES IRELAND LTD. ACRYSOF INTRAOCULAR LENS &nbsp; </span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;TEXT-ALIGN:right;" align="right"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a>back to search results</a></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:3.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:3.75pt;BACKGROUND:#f9f9f3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ffffff;" vAlign="top">
<table class="MsoNormalTable" cellSpacing="0" cellPadding="0" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Model Number</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;"> SN60AT</span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Device Problems</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> Lens, opacification of; Lens replacement </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Event Date</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">&nbsp;</span><span lang="EN-US" style="FONT-FAMILY:新細明體;">07/13/2009</span><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Event Type</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;">&nbsp; Injury &nbsp; <strong>Patient Outcome</strong>&nbsp; Required Intervention; </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a href="http://www.fda.gov/cdrh/medicaldevicesafety/" target="_blank"><strong>Search Alerts/Recalls</strong></a> </span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="COLOR:#23238e;FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="4%">
<p class="MsoNormal" style="MARGIN:0pt;">&nbsp;</p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:3.75pt;BORDER-TOP:#ece9d8;PADDING-LEFT:3.75pt;BACKGROUND:#e9e9e3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ece9d8;WIDTH:95.48%;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" width="95%" colSpan="3">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="3" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">ALCON RESEARCH LTD. / </span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">HUNTINGTON</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> ACRYSOF INTRAOCULAR LENS &nbsp; </span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;TEXT-ALIGN:right;" align="right"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a>back to search results</a></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="4%">
<p class="MsoNormal" style="MARGIN:0pt;">&nbsp;</p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:3.75pt;BORDER-TOP:#ece9d8;PADDING-LEFT:3.75pt;BACKGROUND:#f9f9f3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ece9d8;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" colSpan="3">
<table class="MsoNormalTable" cellSpacing="0" cellPadding="0" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Model Number</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;"> MA60BM</span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Device Problems</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> Lens, opacification of; Device remains implanted </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Event Date</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">&nbsp;</span><span lang="EN-US" style="FONT-FAMILY:新細明體;">12/01/2008</span><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Event Type</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;">&nbsp; Other &nbsp; <strong>Patient Outcome</strong>&nbsp; Other; </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a href="http://www.fda.gov/cdrh/medicaldevicesafety/" target="_blank"><strong>Search Alerts/Recalls</strong></a> </span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="4%">
<p class="MsoNormal" style="MARGIN:0pt;">&nbsp;</p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:3.75pt;BORDER-TOP:#ece9d8;PADDING-LEFT:3.75pt;BACKGROUND:#e9e9e3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ece9d8;WIDTH:100%;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" width="100%" colSpan="4">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="3" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">ALCON RESEARCH LTD/</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">HUNTINGTON</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> ACRYSOF INTRAOCULAR LENS &nbsp; </span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;TEXT-ALIGN:right;" align="right"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a>back to search results</a></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:3.75pt;BORDER-TOP:#ece9d8;PADDING-LEFT:3.75pt;BACKGROUND:#f9f9f3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ece9d8;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" colSpan="4">
<table class="MsoNormalTable" cellSpacing="0" cellPadding="0" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Model Number</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;"> SN60WF</span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Device Problems</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> Lens, opacification of; Device remains implanted </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Event Date</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">&nbsp;</span><span lang="EN-US" style="FONT-FAMILY:新細明體;">01/01/2008</span><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Event Type</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;">&nbsp; Injury &nbsp; <strong>Patient Outcome</strong>&nbsp; Required Intervention; </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a href="http://www.fda.gov/cdrh/medicaldevicesafety/" target="_blank"><strong>Search Alerts/Recalls</strong></a> </span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:3.75pt;BORDER-TOP:#ece9d8;PADDING-LEFT:3.75pt;BACKGROUND:#e9e9e3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ece9d8;WIDTH:100%;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" width="100%" colSpan="4">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="3" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">ALCON RESEARCH, LTD. / </span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">HUNTINGTON</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> ACRYSOF INTRAOCULAR LENS &nbsp; </span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;TEXT-ALIGN:right;" align="right"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a>back to search results</a></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:3.75pt;BORDER-TOP:#ece9d8;PADDING-LEFT:3.75pt;BACKGROUND:#f9f9f3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ece9d8;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" colSpan="4">
<table class="MsoNormalTable" cellSpacing="0" cellPadding="0" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Model Number</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;"> MA60BM</span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Device Problems</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> Lens, deposits on; Lens, opacification of </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Event Date</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">&nbsp;</span><span lang="EN-US" style="FONT-FAMILY:新細明體;">07/02/2008</span><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Event Type</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;">&nbsp; Injury &nbsp; <strong>Patient Outcome</strong>&nbsp; Required Intervention; </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a href="http://www.fda.gov/cdrh/medicaldevicesafety/" target="_blank"><strong>Search Alerts/Recalls</strong></a> </span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:3.75pt;BORDER-TOP:#ece9d8;PADDING-LEFT:3.75pt;BACKGROUND:#e9e9e3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ece9d8;WIDTH:100%;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" width="100%" colSpan="4">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="3" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">ALCON RESEARCH, LTD./</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">HUNTINGTON</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> ACRYSOF INTRAOCULAR LENS &nbsp; </span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;TEXT-ALIGN:right;" align="right"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a>back to search results</a></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:3.75pt;BORDER-TOP:#ece9d8;PADDING-LEFT:3.75pt;BACKGROUND:#f9f9f3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ece9d8;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" colSpan="4">
<table class="MsoNormalTable" cellSpacing="0" cellPadding="0" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Model Number</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;"> MA60BM</span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Device Problem</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> Lens, opacification of </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Event Date</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">&nbsp;</span><span lang="EN-US" style="FONT-FAMILY:新細明體;">01/01/2008</span><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Event Type</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;">&nbsp; Other &nbsp; <strong>Patient Outcome</strong>&nbsp; Other; </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a href="http://www.fda.gov/cdrh/medicaldevicesafety/" target="_blank"><strong>Search Alerts/Recalls</strong></a> </span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="1%" colSpan="2">
<p class="MsoNormal" style="MARGIN:0pt;">&nbsp;</p>
</td>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;BACKGROUND:#888888;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;" vAlign="top">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="1" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:3.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:3.75pt;BACKGROUND:#e9e9e3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ffffff;WIDTH:100%;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ffffff;" vAlign="top" width="100%">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="3" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">ALCON RESEARCH, LTD./</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">HUNTINGTON</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> ACRYSOF INTRAOCULAR LENS &nbsp; </span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;TEXT-ALIGN:right;" align="right"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a>back to search results</a></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:3.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:3.75pt;BACKGROUND:#f9f9f3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ffffff;" vAlign="top">
<table class="MsoNormalTable" cellSpacing="0" cellPadding="0" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Model Number</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;"> SN60AT</span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Device Problems</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> Lens, opacification of; Device remains implanted </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Event Date</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">&nbsp;</span><span lang="EN-US" style="FONT-FAMILY:新細明體;">01/01/2008</span><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Event Type</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;">&nbsp; Other &nbsp; <strong>Patient Outcome</strong>&nbsp; Other; </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a href="http://www.fda.gov/cdrh/medicaldevicesafety/" target="_blank"><strong>Search Alerts/Recalls</strong></a> </span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="COLOR:#23238e;FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="4%">
<p class="MsoNormal" style="MARGIN:0pt;">&nbsp;</p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:3.75pt;BORDER-TOP:#ece9d8;PADDING-LEFT:3.75pt;BACKGROUND:#e9e9e3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ece9d8;WIDTH:100%;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" width="100%" colSpan="4">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="3" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">ALCON RESEARCH, LTD./</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">HUNTINGTON</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> ACRYSOF INTRAOCULAR LENS &nbsp; </span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;TEXT-ALIGN:right;" align="right"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a>back to search results</a></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:3.75pt;BORDER-TOP:#ece9d8;PADDING-LEFT:3.75pt;BACKGROUND:#f9f9f3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ece9d8;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ece9d8;" vAlign="top" colSpan="4">
<table class="MsoNormalTable" cellSpacing="0" cellPadding="0" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Model Number</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;"> SN60AT</span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Device Problems</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> Lens, opacification of; Device remains implanted </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Event Date</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">&nbsp;</span><span lang="EN-US" style="FONT-FAMILY:新細明體;">01/01/2008</span><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Event Type</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;">&nbsp; Other &nbsp; <strong>Patient Outcome</strong>&nbsp; Other; </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a href="http://www.fda.gov/cdrh/medicaldevicesafety/" target="_blank"><strong>Search Alerts/Recalls</strong></a> </span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="1%" colSpan="2">
<p class="MsoNormal" style="MARGIN:0pt;">&nbsp;</p>
</td>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;BACKGROUND:#888888;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;" vAlign="top">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="1" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:3.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:3.75pt;BACKGROUND:#e9e9e3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ffffff;WIDTH:100%;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ffffff;" vAlign="top" width="100%">
<table class="MsoNormalTable" style="WIDTH:100%;" cellSpacing="3" cellPadding="0" width="100%" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">ALCON LABORATORIES, INC. / </span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">HUNTINGTON</span></strong><strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> ACRYSOF INTRAOCULAR LENS &nbsp; </span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:0.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:0.75pt;PADDING-BOTTOM:0.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:0.75pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;TEXT-ALIGN:right;" align="right"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a>back to search results</a></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:3.75pt;BORDER-TOP:#ffffff;PADDING-LEFT:3.75pt;BACKGROUND:#f9f9f3;PADDING-BOTTOM:3.75pt;BORDER-LEFT:#ffffff;PADDING-TOP:3.75pt;BORDER-BOTTOM:#ffffff;" vAlign="top">
<table class="MsoNormalTable" cellSpacing="0" cellPadding="0" border="0">
<tbody>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="COLOR:fuchsia;FONT-FAMILY:新細明體;">Model Number</span></strong><span lang="EN-US" style="COLOR:fuchsia;FONT-FAMILY:新細明體;"> MA30BA</span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Device Problems</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"> Lens, opacification of; Lens replacement </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">Event Date</span></strong><span lang="EN-US" style="FONT-FAMILY:新細明體;">&nbsp;</span><span lang="EN-US" style="FONT-FAMILY:新細明體;">01/01/2007</span><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Event Type</span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;">&nbsp; Injury &nbsp; <strong>Patient Outcome</strong>&nbsp; Required Intervention; </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Event Description </span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="COLOR:fuchsia;FONT-FAMILY:新細明體;">A surgeon reports that following intraocular lens (iol) implant surgery, a pt&#39;s lens is opaque. The iol was exchanged. Add&#39;l info has been requested. </span></strong></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span>&nbsp;</p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><strong><span lang="EN-US" style="FONT-FAMILY:Arial;">Manufacturer Narrative </span></strong><span lang="EN-US" style="FONT-FAMILY:Arial;"></span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;">The product was not returned for analysis. Product history records could not be reviewed because the reporting facility did not provide a lot number or any identification traceable to the mfg documentation. Add&#39;l info has been requested. </span></p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span>&nbsp;</p>
</td></tr>
<tr>
<td style="BORDER-RIGHT:#ffffff;PADDING-RIGHT:1.5pt;BORDER-TOP:#ffffff;PADDING-LEFT:1.5pt;PADDING-BOTTOM:1.5pt;BORDER-LEFT:#ffffff;PADDING-TOP:1.5pt;BORDER-BOTTOM:#ffffff;BACKGROUND-COLOR:transparent;">
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"><a href="http://www.fda.gov/cdrh/medicaldevicesafety/" target="_blank"><strong>Search Alerts/Recalls</strong></a> </span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-FAMILY:新細明體;"></span></p>
</td></tr></tbody></table>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="COLOR:#23238e;FONT-FAMILY:Arial;"></span></p>
</td>
<td style="BORDER-RIGHT:#ece9d8;PADDING-RIGHT:0pt;BORDER-TOP:#ece9d8;PADDING-LEFT:0pt;PADDING-BOTTOM:0pt;BORDER-LEFT:#ece9d8;PADDING-TOP:0pt;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="10%">
<p class="MsoNormal" style="MARGIN:0pt;">&nbsp;</p>
</td></tr>
<tr height="0">
<td style="BORDER-RIGHT:#ece9d8;BORDER-TOP:#ece9d8;BORDER-LEFT:#ece9d8;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="4"></td>
<td style="BORDER-RIGHT:#ece9d8;BORDER-TOP:#ece9d8;BORDER-LEFT:#ece9d8;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="8"></td>
<td style="BORDER-RIGHT:#ece9d8;BORDER-TOP:#ece9d8;BORDER-LEFT:#ece9d8;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="1082"></td>
<td style="BORDER-RIGHT:#ece9d8;BORDER-TOP:#ece9d8;BORDER-LEFT:#ece9d8;BORDER-BOTTOM:#ece9d8;BACKGROUND-COLOR:transparent;" width="52"></td></tr></tbody></table></div>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US"><font face="Times New Roman" size="3"></font></span>&nbsp;</p>
<p><br>&nbsp;</p>]]></description>
            <pubDate>Tue, 27 Oct 2009 23:53:53 +0800</pubDate>
            <guid><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4452]]></guid>
         </item>         <item>
            <title><![CDATA[尊嚴不是無代價的 /薩蘇]]></title>
            <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4443]]></link>
            <description><![CDATA[<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">尊嚴不是無代價的<span lang="EN-US"> /薩蘇</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">我如死了，「就看不到奪回台灣了」<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">【聯合報╱龔濟／文字工作者（臺北市）】<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">2009.10.26 03:32 am</font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">?</font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">昨天是「台灣光復節」。但似乎沒聽到、沒看到有人提到這個節日。古寧頭戰役當然值得紀念，但它與光復節不是一件事。 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">只有國民黨在若干報紙上登了一幅廣告：「台灣光復／中華民國的榮耀」。不知怎麼的，看起來就是怯生生的，有點「羞於啟齒」的樣子。 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">這也難怪，台灣本身的存在都有人不以為然了，還談什麼「光復節」？ <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">一位前任總統涉嫌貪瀆坐在牢裏，忽然記起台灣還是「美國佔領地」，緊急「上書」華府，要求美國軍事法庭快來解救他。另一位前總統因為「廿歲以前還是日本人」，就要把宜蘭縣轄地釣魚台拱手送給日本。現任的這位總統，據說是一個溫良恭儉讓的人，不免八方討好，既然有人不喜「光復節」這三個字，那就別提吧！ <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">那些「不喜」的人，心頭有個成見：中國八年抗戰，怎知一定是為了台灣？ <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">那就讓一位中國兵士回答這個問題。 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">河南人薩蘇，一九九二年自北京師範大學畢業，先後在美國通用電氣、<span lang="EN-US">AT&amp;T和諾基亞等公司任職，現為一家外商駐日部門主管。因地利之便，他暇時蒐集日本未公佈的和民間的中日戰爭資料，陸續在報章上發表，很受各方注意，成了「業餘中日戰史研究家」。二○○七年他出版《國破山河在—從日本史料揭秘中國抗戰》，復旦大學歷史系教授葛劍雄稱讚他「在尊重事實，實事求是方面，不亞於歷史學者」。 </span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">從侵華日軍的材料中，薩蘇發現一個叫齋藤的士兵，記錄他在前線和一個中國兵的對話，非常動人。薩蘇翻譯加講解，放在他的書裏。 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">齋藤在湖南修水前線作戰，戰鬥間歇，他到一條河邊，用汽油桶洗水果，不小心桶被沖走，日本兵跟在後面追，卻發現汽油桶漂向了對岸。這時，他看到對岸有個正在洗澡的中國兵，雙方都大吃一驚。因為都沒有帶槍，誰也沒法射擊。那中國兵慢慢站起身來，拾起汽油桶，取出一個水果咬了一口，向後面的樹林退去。 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">這日本兵鬼使神差地用日語問了一句，「好吃嗎？」 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">沒想到這個中國兵居然用日語答道，「謝謝。」 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">看來這可能不是一個普通的中國兵，而是一個下級軍官或士官。出於好奇，這個日本兵繼續問道，「你們過得怎麼樣？發的錢多嗎？」 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">中國兵站住腳步，聳聳肩說，「好幾個月沒有發到餉。」也許覺得這個日本兵很有趣，又補充道，「日子不好過啊！有督戰隊，不好好打仗可能被自己人打死哦。」他沈默了一下，接著說，「那樣我就看不到奪回台灣，看不到佔領大阪，也看不到佔領東京了，多遺憾。」 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">說完，他帶著汽油桶，慢慢走入樹林中。 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇也許知道，抗日期間，政府「十萬青年十萬軍」的號召，使多少優秀大學生奔赴沙場。有會說日語的士兵，應不足為奇。這個青年軍人，把收復台灣放在笫一位，佔領大阪和東京倒在其次。在連天烽火中，那是中國人忘不了的共同的心願和志向。 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">一九八五年抗日勝利四十年，「北美華人社會科學家協會」在美國舉辦紀念性學術研討會。一位聽眾問中研院院士許倬雲，中國抗日付出這麼大代價，意義究竟是什麼？許院士回答他：「中國爭到了國格。國格是一個國家對本身的肯定的一番自覺，及一分由此而生的尊嚴與自重。」他又極帶感情的說：「這是百年屈辱後，中國咬著牙吞著血，拚出來的國格。」 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">中國「百年屈辱」，還有比甲午割台更屈辱的事嗎？八年抗日犧牲了幾千萬軍民同胞的生命，他們用鮮血掙來的國格，今天還有多少人在意？ <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">馬英九總統昨在古寧頭致詞，願殺戮走入歷史，和平成為永恆。這是智者與仁者之言。但我們先要記得殺戮何以來怎樣去，才有資格呼喚和平。 <span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">【<span lang="EN-US">2009/10/26 聯合報】@ http://udn.com/ </span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><a href="http://big5.ifeng.com/gate/big5/book.ifeng.com/book.php?book_id=1130"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">http://big5.ifeng.com/gate/big5/book.ifeng.com/book.php?book_id=1130</font></a></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">尊嚴不是無代價的：著名軍史作<span lang="EN-US">...</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">作　　者：<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">出　　版：<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">山東畫報出版社<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">定　　價：<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">29元</font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">ISBN：</font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">9787807137658</font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">出版日期：<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">2009-02</font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">版　　<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">本書為授權連載，禁止轉載。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">【本書簡介】<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　　　《尊嚴不是無代價的》是著名軍史作家薩蘇《國破山河在》（<span lang="EN-US">2007年出版，入選香港亞洲週刊2007年度華語圈十大好書）的續篇。主要內容同《國破山河在》一樣，通過日方史料和中方記載互證，或重現，或填補了不少中國軍民抗敵衛國的珍貴歷史事跡。薩蘇所使用的日方資料，大多是專業研究者忽視、或者關注不到的塵封在日本資料館、舊書肆，以及私人手裏的老兵回憶、戰時報道、未刊稿件等資料。這部分資料大多是日本侵華人員對自己參與的軍事活動的回憶，雖然立場不同，但真實性高，細節準確。而中方記載，因多為防禦戰和潰敗，資料極其匱乏，尤其是日方損失和戰鬥細節，不是編造就是闕如，日方資料正可豐富這方面的記載。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><a href="http://tw.group.knowledge.yahoo.com/apple-520/article/view?aid=57"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">http://tw.group.knowledge.yahoo.com/apple-520/article/view?aid=57</font></a></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">侵華日軍中不怕吃敗仗的第一窩囊廢師團<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">對萬家嶺會戰有印象的朋友，或許會記得那一仗被薛嶽將軍打得七零八落的日軍第一零六師團，這個師團因為有大量原來在大阪擺攤賣菜的預備役官兵，而被稱為“大阪商販師團”。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　大阪部隊戰鬥力弱，在日軍中算是有名的，而其中最有代表性的部隊，卻還不是一零六師團。在《現代史研究》第六期中，看到一篇日本軍事歷史學家關幸輔的文章<span lang="EN-US"> -- 《日軍第一窩囊廢師團》，看完之後，忍不住要把它翻譯過來。關的原題是《日本一弱???師?》，自以為這題目兄弟的翻譯還是比較貼切。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　下面就是翻譯後的文章。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　如果看伊籐正德的《帝國陸軍之最後》或者山崗莊八的《太平洋戰史》，二戰中的日本軍隊無一不是勇猛頑強，寧死不屈的精銳之師<span lang="EN-US">[薩評：或者應該翻作“個個都是亡命徒”比較好？]。然而，在陸軍混過的老兵，評價起來和歷史學家不大一樣，至少有一支部隊，就以“皇軍中第一窩囊廢師團”而著稱，這就是番號一直保留到今天自衛隊還在使用的大阪第四師團。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　大阪第四師團，代號“澱”<span lang="EN-US">[薩評：這個代號可謂獨出心裁，其他的日本陸軍師團代號多有尚武精神的象徵，比如第二師團是“勇”，第九師團是“武”等等，第四師團這個“澱”字的來源是因為有一條澱川河橫穿大阪最繁華的梅田商業區，用這個代號真是既有鄉土氣息，又帶有招財進寶的吉利。。。]屬於日軍中的資格最老的師團之一，下轄四個聯隊，標准甲等配備，其核心為第八聯隊，因在日俄戰爭中屢戰屢敗，獲得“敗不怕的八聯隊”之勇名（？）[薩評：這個帶括弧的問號來自原文，不是薩加的]。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　從那兒以後，直到<span lang="EN-US">1937年中日戰爭全面爆發，雖然中間戰事不斷，第四師團卻一次都沒上過前線。不過，這並不等於第四師團沒有表現自己勇敢精神的機會。昭和八年，第四師團二等兵松井洋二在大阪市中心闖紅燈和執勤員警發生沖突，事情越鬧越大，最後師團長寺內壽一為了“維護大日本皇軍的尊嚴”，毅然帶兵砸了員警所，史稱“大阪Go-Stop事件”，第四師團的“武勇”可見一斑。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　昭和十二年，也就是一九三七年，因駐華日軍兵力吃緊，日本陸軍大本營將第四師團調到中國東北，劃歸關東軍序列。第四師團的戰鬥力已經在“<span lang="EN-US">Go-Stop事件”中得到了充分的反映，可惜，這種“勇猛無前”的例子只此一例，倒是對第四師團軍紀散漫，精神不振的報告屢屢上達天聽。怎樣讓這支部隊煥發戰鬥精神呢？日軍大本營倒是費了一番心思，結論是指揮官對於一支部隊的戰鬥力具有決定性的作用[薩評：所謂“兵熊熊一個，將熊熊一窩”的理論，這聽起來挺有道理。。。]，於是調名將山下奉文[薩評：綽號“馬來之虎”，在新加坡打得英將柏西瓦爾烏江上吊的那個]擔任第四師團師團長，從此，該師團主力即開始在“北滿的山野中精訓</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">名將帶隊，精訓兩年，轉眼到了一九三九年，東北發生了一件重大戰事 – 蘇日諾門坎之戰，關東軍和朱可夫將軍的蘇蒙聯軍打起來了，而且戰況不利，軍部下令駐紮在偽滿北部的大阪，仙台兩師團緊急動員，增援前線。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　仙台師團，就是前面提到的代號“勇”的第二師團<span lang="EN-US">[薩評：日軍著名的精銳師團，最後在增援瓜達爾卡納爾島航渡途中碰上了個美國航空兵部隊叫“仙人掌”，一通狂轟濫炸，整個師團下了餃子，和?魚勇猛搏鬥去了。]，的確名不虛傳，其先遣隊新發田第十六聯隊勇往直前，從海拉爾到諾門坎，徒步行軍四天趕到，當天就投入戰鬥[薩評：隨後就被蘇軍打了個落花流水，死傷慘重]。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　與此相反，第四師團的出動命令雖然下達，卻遲遲不動。原因是動員令下達後，師團內的急病患者激增，放眼望去，滿營都是因為五花八門原因要求留守的官兵。激動<span lang="EN-US">[薩評：激動得有道理]的聯隊長怒而親自坐鎮醫務室，參加診斷[薩評：聯隊長改行當大夫，有前途的職業阿]。饒是如此，出動部隊的編成也不是件容易的事情，從海拉爾到諾門坎，第二師團走了四天，第四師團卻整整走了八天，而且大量人員掉隊。湊巧的是，第四師團先遣隊到達前線的當天，蘇日宣佈停戰了。。。立刻，掉隊的第四師團官兵仿佛吃了大力丸[薩評：這個是薩的意譯，原文的意思是“驟然充滿活力”]一樣迅速跟了上來，連留守的官兵也有不少“帶病”趕赴前線，一邊還在萬分懊喪的抱怨居然沒有機會打上一仗。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">返程的時候，齊裝滿員，精神飽滿的第四師團，成了最威武的部隊，丟盔卸甲，傷兵滿營的第二師團和人家簡直沒法比，只是關東軍報道部的上層實在看不過眼，把報紙呈上來的《我無敵皇軍第四師團威勢歸來》的新聞標題改了一個字，變成了《我無傷皇軍第四師團威勢歸來》，外行看來意思相差不大，當兵的看了，對第四師團的名聲肯定是沒什麼好處。。。<span lang="EN-US">[薩評：看來司令官雖然重要，畢竟不能扭轉乾坤，可憐山下奉文在日軍中稱為“鬥將”，這次成了“將雄熊一窩”也。]</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　不過第四師團這一仗沒有損失對日本軍部來說應該是個好消息，因為當時華中地區的日軍正和中國軍隊第九戰區鬥得難解難分，急需增援，於是顧不上追究，急調第四師團南下增援。大阪師團搖身一變，又成了日軍精銳十一軍中的一員。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　其實，第四師團的名聲，中國軍隊早有所聞，其原因是早在一九三八年初徐州會戰期間，中國軍隊就遇到過一支“奇怪的日軍”。當時，中國軍隊從徐州突圍向西“轉進”，<span lang="EN-US">[薩評：李宗仁司令長官的得意之作，四十萬大軍巧妙跳出了日軍的包圍圈。雖說李長官的戰術動作果斷俐落，畢竟機動能力和已經半機械化的日軍無法相比，突圍雖然成功，但已經是人困馬乏，重裝備也丟失很多，戰鬥力銳減。]在過魯蘇皖邊境一條公路的時候，疲憊的中國軍隊忽然發現同一條路上出現了一支裝備精良的日軍部隊，數量最少一個大隊！</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　因為部隊已經十分疲憊，士氣低落，這支中國軍隊發現敵軍之後驚惶失措，混亂地離開公路向附近的山區逃離。以當時日軍計程車氣和作戰習慣，中國軍隊幾乎肯定會遭到追擊，而以當時中國軍隊的狀態，一個大敗仗恐怕是跑不了的。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　奇怪的是，很久卻沒有發現日軍的追兵，中國軍隊的指揮官驚奇之餘派人打探，卻見那支日軍如臨大敵地佈置了警戒哨，但絲毫沒有追擊的意思，相反，還在公路兩側堂而皇之的燒起飯來！<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　時間緊迫，繞道的話說不定就會被日軍合圍，中國軍隊橫下一條心，硬著頭皮橫穿公路而走，結果 – 一路平安。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　這支日軍部隊，就是抽調第三十七聯隊，第七十聯隊各一部組成的第四師團南進支隊，對於為何沒有和中國軍隊開戰，該部隊的部隊長聲稱：“沒有得到對中國軍大部隊進行截擊的命令。”而這個嚴格遵守作戰紀律的部隊，上報情況就略微的慢了一點，等命令到達的時候，中國軍隊早就沒了影子。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">消息傳到中國軍隊耳朵裡，“大阪的日本兵不會打仗”這樣的說法就流行開來，於是這次第四師團南下，每次參戰，中國軍隊一聽是“大阪師團”，往往士氣倍增，踴躍突襲逆襲，各部搶著和第四師團交戰。在這種莫名其妙的有力打擊下，剛到前線的第四師團猝不及防，確實吃了幾個窩囊的敗仗<span lang="EN-US">[薩評：的確“不負眾望”]，這樣的情況甚至牽連了友軍，以至於友鄰部隊向十一軍司令部抱怨 – “有第四師團參戰，本來能打贏的仗，因為敵軍士氣大振，也會打輸。。。”第十一軍看看的確是這道理，自此同樣是甲等配置的師團，前線出現的番號就總是第三，第十三這樣的師團，而第四師團就專心在後方“待機”了。中間出了個軍司令官不信邪，派第四師團在長沙會戰中打主攻，結果第四師團一進長沙就被趕了出來，全線潰敗，司令官灰頭土臉地回了日本[薩評：這個司令官，可能說的是阿南惟己。阿南是個死硬派，腦袋一根筋，打到吃了兩個原子彈，天皇都要投降了他還准備發動政變和盟軍死磕，結果兵敗自殺，守長沙的國軍是老虎仔薛嶽所部精銳，也只有阿南這種榆木腦袋會用第四師團當主攻。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">長沙會戰中第四師團的表現給它帶來了極大的負面影響，結果就是澱兵團成了“喪門星”，哪個軍都不敢要。大本營只好將其改為直轄部隊，長期駐紮上海。<span lang="EN-US">[薩評：這下第四師團的兵有的吹了 – 老子當兵就在甲種師團，開戰時候屬於關東軍 – 精銳，仗打起來在十一軍 – 還是精銳，最後十一軍裝不下我們了，只好改大本營來直轄。。。]這回中國軍隊就想打第四師團都夠不著，無奈又發生了第四師團人員向中共軍的新四軍倒賣藥品的事情，讓大本營十分懊惱。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　雖然說第四師團窩囊，畢竟是甲種師團，老兵多，有經驗的下級軍官多。當時日軍前線各師團和中國軍隊作戰損失很大，急需補充訓練有素的人員，既然第四師團作為整體作戰不利，上司便不時抽調其人員補充到其他師團，也算是物盡其用。然而，這些人員的作用可就不好說了。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　第一零六師團本來就也是出身大阪，所以第四師團的補充官兵來了以後很容易適應，而他們的老鄉也不時從第四師團過來探望。一零六師團的官兵很快就發現他們之間的告別很新鮮。日軍各部的臨別致詞（挨拶）都有自己的特色，比如第二師團的官兵告別時，如果戰況較好，就說“武運長久”，如果情況不妙，就說“九段<span lang="EN-US">?見” [薩評：靖國神社在東京九段?，不過這句“九段?見”明擺著咒對方挨槍子兒，大有“打死你我也不說”的精神]。然而，第四師團的官兵告別時，其詞卻是：“保重貴體” [薩評：原文</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">“禦身大切”，也可以翻譯作“身體第一”，或者乾脆就是“保命最重要”<span lang="EN-US">]，讓聽到的一零六師團軍官們啞然。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">　　還有一部分兵員轉到了第六十八師團和第三十四師團。這兩個師團在衡陽和芷江打了幾場苦戰。戰鬥一開始，第四師團的老兵又故伎重演，從軍官，士官到老兵紛紛入院，消極但合理地拒絕作戰。當然，也有些人循規蹈矩的投入了戰鬥。這一段時間的戰鬥中國軍隊投入了極大的力量，師團損失很大，芷江一戰，從第四師團轉來的中隊長就戰死了四個。負傷的老兵到醫院的時候那些“養病”的前輩們還要問 – “你為什麼要這樣玩命阿？”至於自己不願意參戰的原因麼，也有老兵這樣解釋 – 聽說這次出擊我們是擔任佯攻的，這很沒有意思，如果是主攻麼，那自然是要好好打一仗<span lang="EN-US">?。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><a href="http://74.6.146.127/search/cache?ei=UTF-8&amp;p=%E8%96%A9%E8%98%87&amp;fr=yfp&amp;u=www.dwnews.com/big5/MainNews/Military/ifeng_2009_09_30_6_45_56_524.html&amp;w=%E8%96%A9%E8%98%87&amp;d=SUBAZt29TpyS&amp;icp=1&amp;.intl=tw&amp;sig=Pkoaz1kXbN24l0rjdGkTaA--"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">http://74.6.146.127/search/cache?ei=UTF-8&amp;p=%E8%96%A9%E8%98%87&amp;fr=yfp&amp;u=www.dwnews.com/big5/MainNews/Military/ifeng_2009_09_30_6_45_56_524.html&amp;w=%E8%96%A9%E8%98%87&amp;d=SUBAZt29TpyS&amp;icp=1&amp;.intl=tw&amp;sig=Pkoaz1kXbN24l0rjdGkTaA--</font></a></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕八路軍還消滅過日本坦克部隊<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕《鏘鏘三人行》﹐查老師咱們請來這個薩蘇老師﹐他按說跟我是老鄉﹐都出生在北京吧﹖是河北人﹐對吧。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇（旅日華人）﹕出生在北京﹐老家是河北。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕這正正經經的是一中國人﹐但是長期潛伏在日本﹐為我們搞情報﹐你知道他有一個﹐我覺得很有意思的一個角度﹐他這個角度就是對於抗日戰爭很多的歷史﹐我們知道的是什麼﹖他呢在日本﹐通過日本方面的軍史﹐或者很多很多的回憶錄﹐很多日本方面的史料﹐發現了一些被我們的抗日戰爭史忽略的﹐甚至你從來不知道的﹐一些戰鬥。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">這個角度非常的有意思﹐你比如像我們通常說起來﹐咱們知道什麼﹖我覺得最近﹐這兩年這個歷史有點意思﹐過去幾十年我一直以為抗日戰爭﹐是咱們共產黨打的嘛﹐國民黨就在後面搗亂呢﹐對吧﹖但是這兩年我們讓歷史透明了一些﹐也出現了另一個傾向﹐就宣傳宣傳﹐現在又有人感覺呢﹐像是抗日戰爭全是國民黨打的﹐共產黨是“遊而不擊”﹐保存實力。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕只有一個百團大戰﹐然後什麼都沒有。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕這說起來百團大戰﹑平型關大捷﹐什麼阿部規秀就不知道什麼了嘛﹐但是它在日本軍的史料當中﹐這幾天我看了好多﹐至少你比如說在咱們河北﹐晉察冀共產黨八路軍打過很多仗﹐甚至你都想不到﹐咱們這兒一時你查不出來﹐咱們打下過日本的偵察機。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕對。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕這事兒在過去我也不知道。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕是﹐八路軍還消滅過日本坦克部隊呢。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕拿什麼坦克消滅小米加步槍。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕這個比小米加步槍那個武器還要古怪﹐這個事情可以稍微講一講。是這樣的我在日本看到一本資料﹐叫做《春兵團戰鬥記》﹐經過後來我查這本春兵團它是日本混成第<span lang="EN-US">8旅團﹐所以我後來又查日本混成第8旅團的團史﹐終於證明瞭這件事﹐很有意思﹐這件事情在八路軍戰史裡面反而沒有人提到﹐就是在山東曹各莊﹐可惜不是在咱們河北。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕我是山東人哪﹐祖籍山東。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕他也遊擊﹐他是遊籍。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">正在加載中<span lang="EN-US">...</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕在山東曹各莊﹐也許大家可以查一下這個地方﹐中國的八路軍曾經消滅過一支日軍的坦克部隊。當時是這樣的﹐由於當地出現了八路軍的活動﹐所以日軍派出一支坦克部隊和一支步兵部隊一起前去襲擊這個地方。去襲擊的時候﹐寫這個文章的人日本兵﹐是在步兵部隊裡﹐他說“看到到處都是八路”﹐於是他們步兵就和八路軍展開了戰鬥﹐這個時候坦克已經沖進了村裡﹐從此就沒有消息了。因為日本的坦克和後來坦克不一樣﹐他們不喜歡用裡面的電話﹐就是電報通訊設備﹐那個設備不太可靠﹐經常發出很奇怪﹑很大的噪音﹐所以日本兵在裡面本來就悶罐一樣的﹐再發出那種噪音﹐大家想一想他是很難受的﹐他們通常就關了﹐所以他們以為是坦克部隊關了這個通報器沒和他們聯系。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">但是等他們都跑出來﹐就打完了這一仗回來了﹐唉﹐坦克哪兒去了﹖跑濟南去了﹐不大可能﹐然後他們就想﹐到底坦克哪兒去了﹐怎麼也聯系不上這支坦克部隊﹐全軍覆沒了﹐一個活人沒有﹐而且是有照片的。這時候日軍就懷疑了﹐是不是在村子裡發生什麼事了﹐他們馬上就跑到村子裡去看這件事情﹐結果看到了一個非常奇怪的景象﹐就是坦克部隊﹐開始它坦克是分兩路沖進去的﹐正好就被八路軍慢慢的引到了兩條巷子裡。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">而這個巷子﹐可能多少年就這麼造的﹐越來越窄越來越窄﹐最後坦克就成了一路縱隊在裡面走﹐就在巷子的盡頭他找到所有被擊毀的坦克﹐這些坦克完整無損﹐裡面的乘員呢﹐也都身上一點傷都沒有﹐但是上面堆著大量燃燒的玉米秸。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕咱們給它火攻﹖<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕對﹐所以他們就猜到是這樣﹐八路軍的人把他們引進了曹各莊的兩條巷子﹐然後在周圍堆了大量的玉米秸﹐突然傾到了坦克﹐然後點燃﹐結果就造成坦克裡面突然缺氧﹐於是所有乘員都沒有任何的傷﹐但是都死亡了。我有一張照片﹐就是當時他們兩邊日本兵拿著擔架這邊這邊﹐然後中間是一個坦克﹐開著蓋﹐兩個日本兵在往裡看﹐還有活的沒有﹖<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕雖然他們的武器比咱們這邊。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕當時的確是沒法講﹐八路軍那樣的裝備都能夠打坦克。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕十個學生兵換一個日本兵的命<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕所以你看他這個書﹐我就講微觀歷史學﹐很多碎片﹐小細節咱們不知道知其然不知其所以然﹐你比如說當時他就說“七七事變”的時候﹐我就看到他研究一個人叫潘毓桂﹐這個人呢算是當時的一種名士﹐書畫都是非常棒的﹐很有名的這麼一個人﹐到後來審判漢奸的時候﹐他還振振有辭說當時一方面他跟宋哲元等於是哥們。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕對。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕而且他又跟日本人交好﹐所以宋哲元的想法很復雜﹐他是軍閥嘛﹐也想保存實力﹐對吧﹖<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕對。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕也想跟日本人﹐但是到最後他選擇了奮起抗戰﹐他沒有當漢奸。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕對。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">正在加載中<span lang="EN-US">...</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕可是咱們說的像佟麟閣﹑趙登禹這兩個將軍的犧牲﹐跟這個潘毓桂非常有關系﹐因為什麼﹖你想﹐我覺得當時中國軍隊當時這個窩囊給打的作戰計劃﹐因為宋哲元制定的南苑﹐打南苑的作戰計劃﹐剛開完會﹐潘毓桂就把全盤的作戰計劃交給日本人。他為了就說﹐跟日本人就說你看﹐我是真的要跟你們斡旋﹐你看我多有誠心﹐把這計劃給你們。所以日本人就打南苑嘛﹐一打就打你最薄弱的地方﹐就是學生軍﹐學生軍就是剛參加完“一二九”運動﹐槍才發了幾個小時。但是這幫學生軍居然就沒讓日軍奪了陣地﹐當時是十個換一個。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕而且當時我們中國的大學生﹑中學生有多少。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕對﹐沒錯。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕十個學生的命﹐換他一條命。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕當時就是說﹐跟日本軍打是<span lang="EN-US">1﹕10嘛﹐十個學生﹐然後到最後。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕這個<span lang="EN-US">1﹕10不是一個比例﹐不是那麼說的比例﹐是當時確實有陣亡人數在裡面計算的。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕這個漢奸最後殺了沒有﹖<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕不是﹐你說他覺得﹐你想他這個想法﹐這個潘毓桂他的想法﹐他說當時國民政府在南邊﹐鞭長莫及。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕對。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕我是為了華北平津老百姓著想﹐怎麼辦呢﹖只有投靠日本。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕並且希望<span lang="EN-US">29軍盡快戰敗﹐趕緊離開這個地方。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕不是﹐曲線救國這一批整個汪偽政權﹐不都是這種思維﹑思想嘛﹐就是打不過﹐反正你要認現實的話﹐打不過﹐那你就別來硬的﹐硬的最後玉石俱焚了﹐咱們還是軟的﹐包括文藝界的這些什麼周作人留在北京。他好像還是在任了什麼職﹐但是他都有他的說法﹐他有他的想法﹐包括推動日化教育﹐你想他那麼瞭解日本的一個人﹐娶了日本老婆之後﹐他其實不是那麼簡單的﹐就是一個漢奸﹐我覺得。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕談到周作人﹐你就可以談到這抗戰之中的一些事情﹐你像周作人是娶了日本老婆的﹐所以他又處在抗戰之中﹐他採取了這種態度。其實當時在中國﹐同樣是他這個位置﹐也是娶了日本妻子的﹐我覺得有三人﹐都可以說一說。第一階段是周作人這樣的﹐周作人這樣的就是說我娶了﹐因為我很熟悉日本﹐他把日本稱作第二故鄉﹐我就完全按照日本的走﹐日本人說的是對的﹐的確趕緊把<span lang="EN-US">29軍打敗了﹐我就在這邊好好過日子吧﹐他那樣的。第二個是郭沫若﹐郭沫若先生他也是在日本娶了日本太太的﹐他當時做的事情是什麼呢﹖立刻把家扔了﹐馬上回國抗戰。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">那麼這個我的看法是這樣的﹐郭沫若比周作人要強因為他是民族大義在先﹐但是他對不起他自己的妻子﹐那妻子後來找過他。那麼還有一個第三階段﹐這個第三階段是誰呢﹖就是蔣百裡將軍。蔣百裡將軍是當初提出來的﹐就是對日怎樣作戰的這樣一個將軍﹐他早在<span lang="EN-US">1925年就料定中國跟日本必將一戰﹐而且將戰鬥在最後的地方是哪兒﹖襄陽﹑洛陽﹑衡陽﹐非常准確。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕他怎麼也娶日本老婆了﹖<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕佐梅。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">正在加載中<span lang="EN-US">...</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕他娶的妻子是佐梅。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕就日本老梅。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕那麼他是怎麼樣﹐他在中國來﹐就是說作為中國的一個戰略家來指導中國抗戰的﹐那麼他是把日本的妻子帶到中國來﹐然後這個日本妻子是和他一起為中國的傷兵服務。後來蔣百裡將軍在<span lang="EN-US">1938年去世﹐他的幾個孩子都帶出來了﹐都是佐梅夫人給帶出來的。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕男交蔣百裡女交林徽因﹐不負此生<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕現在關心的一塊﹐將來要是萬一中日再交惡﹐您准備怎麼對待您那位日本太太﹖您也把她帶回來﹖<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕您也是日本老婆﹖<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕我倒是覺得說中日現在目前是打不起來﹐但是我以前有一句話說如果生在當時﹐我是男交蔣百裡女交林徽因﹐不負此生也。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕哎呦。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕但是您不會學你剛才贊許那郭沫若吧﹐當即把她蹬了﹐咱們就民族大義為先﹐我覺得這種拿女人做這個的。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕他講這個蔣百裡將軍﹐我覺得英年早逝﹐而且這個人太不得了了﹐他是你知道嘛書畫研究家啊。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕兜裡就一本書就是《文藝復興史》。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕書畫研究家﹐但是又是軍事<span lang="EN-US">&lt;/a&gt;家﹐而且他是一個什麼﹐那就是帷幄之中決勝千裡之外﹐他英年早逝1938年死了﹐可是最後抗日戰爭的進程就是全給他說中了。然後就那個時候﹐他寫的那個叫《國防論》﹐你知道他裡面就有一句話﹐叫什麼﹖千言萬語一句話﹐中國有辦法﹐他那個時候就﹖</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕千言萬語化作一句話﹐中國不是沒有辦法的。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕你說他就研究中日交戰﹐然後他就說中國應該在上海﹐咱就叫淞滬抗戰。讓日軍不要從北往南打﹐讓日軍從東往西打﹐這樣咱們的山﹑河就能夠成為咱的兵力﹐阻擋日軍的裝備和訓練的優勢。最後你看﹐還真就是全給他說中了。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">正在加載中<span lang="EN-US">...</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕而且更厲害的是﹐他就料定中國和日本打成僵持的這個地方在哪兒﹖就是在湖南這個地方﹐他說這是我們中國地理的第二棱線﹐日本打到這兒﹐他就沒有力量了﹐一定會在這兒和我們打成對峙﹐後來戰爭進程果然如他所料。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕天才人物。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕其實我們有一批﹐就是說西風東漸以後﹐有一批知識分子出去留學﹐一部分去西方﹐一部分就是東渡﹐就是從梁啟超他們這一批﹐其實我們有一大批特別瞭解日本的人才﹐不論是學什麼的。你剛才說這位﹐我還想起有一個戴季陶還寫過那個﹐也是國民黨元老﹐我現在記不出具體的話﹐但是他好像也說過一些對日本﹐說得非常到位﹐特別就是犀利的這種話。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕准確的描述。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕就是這種描述﹐可是為什麼這麼多有識之士﹐從日本還都回來了﹐但是就是在抗日戰爭當中﹐實際上我們還是打了八年﹐而且由於整個二戰的這種﹐還得有蘇聯﹑美國的﹐我們才最後才算勝利。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕這叫做巧婦難為無米之炊﹐當時我們中國除了有人才以外﹐就沒有別的什麼東西了。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕我跟你講﹐照他的研究﹐日軍的戰史﹐就是的中國的正規軍只要武器條件基本對等的話﹐因為他沒有空中優勢﹐沒有其他重炮。但是在那種戰鬥﹐就是武器裝置基本對等的情況下﹐我們跟日軍打平手﹐就像他舉那個例子叫什麼﹖就是淞滬抗戰的四行倉庫﹐就是所謂八百壯士守四行倉庫﹐其實好像也就三四百人﹐這日軍打不進來嗎﹖<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕焦土抗戰 中國最後的孩子拿起槍<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕可是這個我也得說一點我自己的看法﹐就是說在這種兵力和火力相等的情況下能打成平手﹐這是抗戰前期的情況。到抗戰後期的時候並不是這樣的﹐即使我們的兵力和火力都和他相等﹐或者甚至稍佔優勢的時候﹐比如說在松山大戰﹐遠征軍這個話題現在很熱﹐松山大戰的時候我們損失<span lang="EN-US">1﹕7﹐那個時候我們還是不能夠完全壓倒他﹐為什麼﹖我是看了當時的很多照片才明白﹐就是當時我們很多照片上都是一些年輕的中國兵在打仗﹐年輕到什麼地步﹖12歲﹐13歲﹐7歲的小孩上前線。那麼我們很難想像當時這種情況﹐其實原因是什麼呢﹖我們始終說中日戰爭是一個大國和一個小國的戰爭﹐我們比它大好幾倍﹐我們幾個人拼他一個總能贏了吧﹖可是中國人這麼講的人沒有意識到這樣﹐就是戰爭打到1944年的時候﹐松山大戰的時候﹐實際上中國的國土已經縮到很小了﹐而且它前面很多戰士﹐能作戰的都犧牲了。這個時候中國沒有兵源了﹐怎麼辦呢﹖只好把我們最後的孩子獻出來。</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕哎呦。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">薩蘇﹕我當時在日本說實話﹐我看到那書我是很傷心的﹐我看到的是什麼﹖我是說中國人為了反法西斯戰爭﹐把我們最後的孩子都獻出來﹐這種感受如果不是在日本﹐看著那樣的史料的時候﹐你是很難想像的﹐我是一個工程師﹐我平時不會這麼激動﹐但就是看到那種史料的時候﹐真是有那種﹐我們中國人真是了不起﹐我們中國人當時什麼也沒有﹐沒有教育﹐孩子們上前線的時候﹐把所有的糧食都塞在身上﹐他為什麼塞在身上﹖因為他們小時候沒有吃過那麼多的糧食﹐他生怕沒有吃的。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">所以日軍把他打死了﹐一看身上全都是糧食。也許大家覺得笑話﹐因為我們這個社會現在感覺不到這個﹐但如果你看到日本那麼多抗戰史料的時候﹐就是日本人眼中的中國人是什麼樣子﹐有很多日本人對我們中國人﹐他其實也是產生很佩服的地方﹐他不是說佩服你能打﹐是佩服你的那種情況下﹐你還能夠堅持下來﹐還在跟我拼﹐你拼什麼呀﹖<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">正在加載中<span lang="EN-US">...</span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style=""><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3">&nbsp;</font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">查建英﹕中國人有這個﹐你這麼一說﹐我都想起來﹐就是當年英國的榮赫鵬去打西藏人的時候﹐後來他也是非常殘酷﹐這個武器完全不對等﹐就是藏軍的武器﹐完全就是什麼一些（沖子槍音對）什麼這些﹐長矛什麼的﹐英軍就是所向無敵﹐完全是橫掃。可是死了以後﹐就是藏人那種英勇﹐贏得了英國軍官的尊敬﹐之後他們就是說﹐那些人死了以後﹐他們勝利了以後﹐英國軍官都吃不下飯去﹐就是都那個就是默哀﹐因為你尊敬你的一個勇敢的﹐雖然完全跟你武力不相當﹐但是勇敢的一個敵人。然後我覺得﹖<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕那個時候我印象很深﹐就是林徽因寫過一首詩﹐我覺得這是一個女人的那種呼喚﹐就是她在大西南的時候﹐有一些我們的飛行員﹐都是年輕小夥子﹐常到她們家吃飯﹐就管她叫姐姐﹐她覺得那是她弟弟。但是她這些弟弟﹐都在天上犧牲了﹐她寫那個詩的意思﹐就是我們的國家﹐這麼落後的飛行﹐明知道打不過他們的飛機﹐但是我們的青年就駕駛飛機上天﹐就是大好青年哪﹐她就覺得這個心痛啊﹐這是。咱們去一下廣告﹐《鏘鏘三人行》廣告之後見。<span lang="EN-US"></span></font></font></span></p> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span style=""><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">竇文濤﹕咱們這個薩蘇啊﹐滿腔性情﹐就講起當年這個抗戰的義士。而且]]></description>
            <pubDate>Mon, 26 Oct 2009 23:29:56 +0800</pubDate>
            <guid><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4443]]></guid>
         </item>         <item>
            <title><![CDATA[世衛：長期用手機　罹患腦瘤,腮腺瘤風險高]]></title>
            <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4442]]></link>
            <description><![CDATA[<div class="bd">
<h1>世衛：長期用手機　罹患腦瘤風險高</h1>
<div class="offer"><a href="http://tw.rd.yahoo.com/referurl/news/logo/tvbs//SIG=10vc53r83/*http://www.tvbs.com.tw/index/" target="_blank"><img alt="TVBS" src="http://l.yimg.com/f/i/tw/news/newspartner2006/tvbs.jpg"/></a> <span>更新日期:<q>2009/10/25 13:06</q></span> <em></em></div>
<div class="w">
<div id="ynwsartcontent">
<p>長期使用手機，健康也會跟著亮起紅燈嗎？世界衛生組織花費10億多<a class="ynwsyq yqclass" id="yui-gen8" title="&#x0053f0;&#x005e63;" href="http://tw.news.yahoo.com/article/url/d/a/091025/8/1tnbe.html?"><span>台幣</span></a>經費，在13個國家地區，進行10年的調查後發現，長期使用手機的人，罹患腦瘤風險偏高，也因此，<a class="ynwsyq yqclass" id="yui-gen9" title="&#x006cd5;&#x00570b;" href="http://tw.news.yahoo.com/article/url/d/a/091025/8/1tnbe.html?"><span>法國</span></a>和英國等國家都打算透過立法，來限制賣手機給<a class="ynwsyq yqclass" id="yui-gen10" title="&#x005152;&#x007ae5;" href="http://tw.news.yahoo.com/article/url/d/a/091025/8/1tnbe.html?"><span>兒童</span></a>。</p>
<p></p>
<p>不管是機場、咖啡廳，還是街道上，人手一機講不停，長時間下來，可能罹患腦癌嗎？醫師：「我們發現，不管是否使用或是常使用手機，都和腦瘤沒有直接關聯。」</p>
<p>腦癌跟手機使用沒有關聯，手機真的對腦神經沒影響嗎？根據世界衛生組織最新研究指出，使用手機10年以上，會破壞人的腦神經，導致腦瘤；研究一出，法國決定將立法，禁止銷售手機給12歲以下的兒童，為了減少暴露於電磁波的危險，英國也不鼓勵兒童講手機。</p>
<p>這項耗費10億8千萬，針對13個國家、1萬2800人，進行長達10年的研究發現，在8項手機研究中，一共有6項都顯示，在罹患腦腫瘤項目裡，最常見的神經膠質瘤，風險增加到39%，<a class="ynwsyq yqclass" id="yui-gen11" title="&#x004ee5;&#x008272;&#x005217;" href="http://tw.news.yahoo.com/article/url/d/a/091025/8/1tnbe.html?"><span>以色列</span></a>研究也顯示，長期使用手機的人，罹患腮腺瘤的風險，高了約50%。</p>
<p>不過這些研究數據，還沒完全確定，長期使用手機和罹患腦瘤，有直接關係，因此專家也只能提出建議，多使用免持聽筒，避免電磁波對腦部，可能帶來的不良影響。</p>
<p></p>
</div></div></div>]]></description>
            <pubDate>Sun, 25 Oct 2009 23:43:19 +0800</pubDate>
            <guid><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4442]]></guid>
         </item>         <item>
            <title><![CDATA[Endophthalmitis Prophylaxis(Ophthalmol Clin N Am )]]></title>
            <link><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4441]]></link>
            <description><![CDATA[<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">Endophthalmitis Prophylaxis</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span lang="EN-US" style="FONT-SIZE:8pt;FONT-FAMILY:AdvTimes;">Ophthalmol Clin N Am 19 (2006) 449–456</span><span lang="EN-US"></span></font></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">Judy I. Ou, MD1, Christopher N. Ta, MD*</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span lang="EN-US">Department of Ophthalmology, </span><span lang="EN-US">Stanford</span><span lang="EN-US"> </span><span lang="EN-US">University</span><span lang="EN-US"> </span><span lang="EN-US">School</span><span lang="EN-US"> of Medicine, </span><span lang="EN-US">900 Blake Wilbur Drive</span><span lang="EN-US">,</span></font></font></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><span lang="EN-US">W3036, </span><span lang="EN-US">Stanford</span><span lang="EN-US">, </span><span lang="EN-US">CA</span><span lang="EN-US"> </span><span lang="EN-US">94305</span><span lang="EN-US">, </span><span lang="EN-US">USA</span><span lang="EN-US"></span></font></font></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;" size="3"></font></span>&nbsp;</p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">Irrigation and intracameral antibiotics </font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff007f"><strong>The use of intracameral antibiotics and antibiotics</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff007f"><strong>in irrigation solution is controversial. Gills</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff007f"><strong>[47] suggested the use of vancomycin (</strong><font color="#000000">20 µg/ml</font><strong>)</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff007f"><strong>in the infusion fluid in order to decrease the rate</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff007f"><strong>of endophthalmitis.</strong></font> Beigi and coworkers [48]</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">showed a statistically significant decrease in positive</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">anterior chamber aspirate cultures (from</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">20% to 2.7%) in a group that received balanced</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">salt solution with vancomycin ( 20 µg/ml) and</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">gentamicin (8 µg/ml) compared with control. In</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">contrast, a paper by Feys and coworkers [49] of</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">372 patients showed no significant difference in</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">bacteria load in the study group that underwent</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">surgery with vancomycin irrigating solution compared</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">with control groups. Cultures of the anterior</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">chamber aqueous fluid can be quite difficult</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">to obtain, however, and the results unreliable</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">[50]. Interestingly, there was a case report of coagulase-</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">negative staphylococcus endophthalmitis after</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">cataract surgery despite the use of intraocular</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">vancomycin (20 mg/mL in 75 mL of balanced saline</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">solution) [51].</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff00ff"><strong>Vancomycin may be toxic to the retina in</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff00ff"><strong>addition to being ineffective. In a prospective,</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff00ff"><strong>randomized, double-masked clinical study of 118</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff00ff"><strong>patients, postoperative cystoid macular edema</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff00ff"><strong>was significantly higher in the study patients</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff00ff"><strong>receiving irrigating balanced salt solution supplemented</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff00ff"><strong>with vancomycin (10 mg/mL?) compared</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff00ff"><strong>with control group (angiographic cystoid macular</strong></font></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff00ff"><strong>edema rate of 55% versus 19% at 1 month;</strong></font> clinical</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">macular edema of 23% versus 7% at 1 month)</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">[52]. Finally, there is increasing bacterial resistance</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">to vancomycin and the Centers for Disease</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">Control and Prevention has advocated against</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">the routine use of vancomycin in intraoperative irrigating</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">bottles [53].</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">Subconjunctival antibiotics</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">Subconjunctival injection of antibiotics is routinely</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">used, although no study has clearly shown</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">a decreased rate of endophthalmitis. In a study by</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">Dallison and coworkers [54], perioperative subconjunctival</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">cephazolin reduced or eliminated lid</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">and conjunctival microflora 48 hours following</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">surgery. In another small retrospective, case control</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">study none of the nine patients with endophthalmitis</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">received perioperative subconjunctival</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">cefuroxime, whereas in the control group 47.8%</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">received perioperative subconjunctival cefuroxime,</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">suggesting that by not using subconjunctival</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">antibiotic injection, this may be associated with an</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">increased rate of endophthalmitis [55]. A trend toward</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">decreasing endophthalmitis rate was seen</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">also with patients who underwent periocular postoperative</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">injection in a cross-sectional German</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">survey [25]. Although there are no studies that</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">clearly show an association between subconjunctival</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">antibiotic injection and decreased endophthalmitis,</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">many surgeons perform this technique given</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">its low risk and toxicity.</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">Endophthalmitis prophylaxis, such as the use of</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">povidone-iodine, has been shown to decrease the</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">rate of endophthalmitis. The use of 5% povidoneiodine</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">and irrigation in the fornices and use of</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">preoperative antibiotics may decrease conjunctival</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">bacterial load and in turn lower the rates of</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">endophthalmitis. In addition, it may be important</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">to apply povidone-iodine and antibiotics at the</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">conclusion of a clear cornea cataract surgery.</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">The role of postoperative subconjunctival antibiotic</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">injection is not clear but has been associated</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">with decreased ocular bacterial flora. Finally,</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">discretion should be used with intracameral antibiotics,</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">especially vancomycin, because data have</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">not been clear regarding efficacy and may lead to</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">cystoid macular edema and increased resistance of</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">bacteria to vancomycin.</font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;">References</font></font></span></p>
<p class="MsoNormal" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:8pt;FONT-FAMILY:AdvTimes;"><font face="Times New Roman">[47] Gills JP.Filters andantibiotics inirrigating solutionfor</font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:8pt;FONT-FAMILY:AdvTimes;"><font face="&#x007d30;&#x00660e;&#x009ad4;">cataract surgery. J Cataract Refract Surg 1991;17:385.</font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:8pt;FONT-FAMILY:AdvTimes;"><font face="&#x007d30;&#x00660e;&#x009ad4;"></font></span>&nbsp;</p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:8pt;FONT-FAMILY:AdvTimes;"><font face="&#x007d30;&#x00660e;&#x009ad4;">==========================================================</font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:8pt;FONT-FAMILY:AdvTimes;"><font face="&#x007d30;&#x00660e;&#x009ad4;">Eye Dr: </font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US" style="FONT-SIZE:8pt;FONT-FAMILY:AdvTimes;"><font face="&#x007d30;&#x00660e;&#x009ad4;">我目前是500 cc &nbsp;<strong><font color="#ff00ff" size="3">irrigating balanced salt solution supplemented</font></strong></font> 
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font color="#ff00ff" size="3"><strong>with vancomycin (7.5 mg) 做為</strong><span lang="EN-US"><font size="3"><font face="&#x007d30;&#x00660e;&#x009ad4;" color="#000000">Endophthalmitis Prophylaxis.</font></font></span></font></font></span></p>
<p class="MsoPlainText" style="MARGIN:0pt;"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font size="3"><span lang="EN-US"><span lang="EN-US"><font face="&#x007d30;&#x00660e;&#x009ad4;"><font size="3"><span lang="EN-US">自2001年後實施</span></font></font></span></span></font></font></span></p>
</span>]]></description>
            <pubDate>Sat, 24 Oct 2009 16:36:36 +0800</pubDate>
            <guid><![CDATA[http://tw.myblog.yahoo.com/Eye-dr/article?mid=4441]]></guid>
         </item>        </channel>
        </rss><!-- w2.blog.tpc.yahoo.com uncompressed/chunked Mon Nov  9 06:26:37 CST 2009 -->
